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ABSTRACT
Highly pathogenic avian influenza (HPAI), subtype H5N1, has continued to infect
humans every year since its initial outbreak in 1997. The overall mortality is
approximately 60% and while the emergence of this avian influenza virus has yet to reach
the Western Hemisphere, its high lethality and pandemic potential warrant attention from
the research community to better understand HPAI disease. Neuroinvasiveness of H5N1
virus is poorly understood and using two HPAI strains of varying lethality in the ferret
model provide a basis for comparing differences in neuropathogenesis and its
contribution to lethality. The studies described herein used two methods of HPAI
exposure in ferrets to elucidate the neuropathogenesis of the virus and its correlation
between neurological signs of infection and lesions within the central nervous system
(CNS). Following both methods of exposure to low doses of a lethal strain of H5N1, we
observed 100% lethality in conjunction with the neurological signs of infection that
correlated with lesions within the CNS. Furthermore, we showed that an H5N1 strain that
does not cause neurological signs does not replicate in the brain and has attenuated
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lethality. We concluded that CNS involvement leads to a poor outcome following H5N1
infection. The increased understanding of the temporal-spatial kinetics of neuroinvasion
and the correlation of neuroanatomical locations of lesions with the neurological signs
observed during these studies could be useful for identifying routes of neuroinvasion and
identifying targets for therapeutics to block CNS entry of HPAI. Finally, understanding
the neurological sequelae of HPAI infection could aid clinicians in a more rapid
diagnosis of influenza infection when patients present with atypical symptoms.
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Chapter 1: Introduction
Background
Influenza viruses cause global epidemics annually and the occasional pandemic, such
as the 1918 “Spanish influenza” and the more recent 2009 H1N1 “Swine flu” pandemic (1).
Three to five million humans are infected with seasonal strains of influenza worldwide each
year with an estimated 250,000 to 500,000 deaths (2). This highly contagious virus is easily
transmissible among humans and an incubation time of approximately one to five days
assists in the widespread transmission of the disease (2, 3). The virus typically causes a mild
or severe respiratory illness that commonly presents as a sudden onset of fever, myalgia, dry
cough, headache, sore throat, runny nose, anorexia, and generally feeling unwell (2, 3).
Vaccines are available for the expected circulating strains of seasonal influenza at the
beginning of the influenza season each year and vaccination has been estimated to prevent
approximately 60% of influenza infections and varies each season (4). Unfortunately, only
about 40% of Americans were vaccinated annually over the past four influenza seasons
(2009-2010, 2010-2011, 2011-2012, 2012-present) leaving the majority of the population
vulnerable to disease (5).
While seasonal influenza viruses are well studied and vaccines are available for
prevention, highly pathogenic avian influenza (HPAI) emerged in humans in 1997 without
any reassortment with a human influenza strain (6-19). Vaccines are under development but
are not readily available and early vaccines have been shown to be ineffective without the
addition of an adjuvant (20-22). As of 15 February 2013, the World Health Organization
(WHO) confirmed cases of H5N1 infection in 620 humans resulting in 367 deaths (59%) in
twelve countries since 2003 (23). Infection with this highly lethal virus manifests in humans
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as fast-progressing pneumonia, respiratory distress syndrome, symptoms in the intestinal
tract and central nervous system (CNS), multi-organ failure, and in fatal cases, death
occurred within ten days of symptom onset (24-27).
As seen with the 2009 swine origin H1N1 pandemic, the introduction of a reassortant
novel virus with unique epitopes to an immunologically naïve population can result in rapid
dissemination (28). The high incidence rate of seasonal influenza coupled with the
emergence of HPAI in humans and the possibility of reassortment suggest HPAI has the
potential to become a highly lethal transmissible virus that could reach pandemic
proportions. Research must continue to further illuminate characteristics of HPAI infection
and viral determinants of lethality in an effort to better identify highly pathogenic emerging
strains and to develop better therapeutics and vaccines to increase the survival of those
infected with or susceptible to HPAI.

Influenza virus structure
Influenza viruses, commonly referred to as “the flu,” are of the Family
Orthomyxoviridae and are enveloped, negative sense, segmented, single stranded RNA
viruses (Figure 1). There are three types of influenza viruses: A, B, and C; where type A and
B commonly infect humans and cause seasonal epidemics; and type C causes mild
respiratory infections and is not believed to cause epidemics. Influenza A viruses are further
subtyped according to the phylogeny of the hemagglutinin (HA) and neuraminidase (NA)
surface glycoproteins. There are 16 distinct HAs and 9 NAs, all found in avian hosts, for a
total of 144 possible subtypes. Typically, H3N2 and H1N1 along with influenza B virus
comprise the seasonal strains that currently circulate in humans while the HPAI subtype
H5N1 is generally restricted to avian species.
2

The influenza virus is a Baltimore class V virus, enveloped with a helical capsid, and
contains eight single stranded negative sense RNA genomes. The eight genomic segments
range in size from 800 to 2,300 nucleotides and encode up to eleven proteins that each have
specific functions. Each viral RNA segment is encapsidated by nucleoprotein (NP) and has a
ribonucleoprotein (RNP) associated with it. The RNP consists of NP and the three
polymerase proteins: polybasic polymerase 1 (PB1), polybasic polymerase 2 (PB2), and
polymerase acid (PA). The envelope is acquired as the virus buds from the host cell and the
surface glycoproteins (i.e., hemagglutinin (HA) and neuraminidase (NA)) protrude from the
envelope in a ratio of 4:1 (HA:NA). These glycoproteins also encompass the epitopes for
antibody recognition and humoral immunity and are the targets of current antiviral
treatments. The glycoproteins also function in viral entry to and exit from the cell. The M2
protein is translated from the matrix (M) segment and is an integral membrane protein that
projects from the envelope and functions as an ion channel necessary for virus uncoating.
Immediately below the lipid bilayer is the matrix protein, M1, known for its interactions with
RNPs and the non-structural protein 2 (NS2). Finally, the nuclear export protein/NS2
(NEP/NS2) is also associated with the virus. The nonstructural protein 1 (NS1) is a multifunctional protein largely known to be an interferon antagonist and can inhibit the host innate
immune response during infection, suppressing host immune and apoptotic responses, and
activating phosphoinositide 3-kinase (PI3K) (29, 30). While the NS1 protein has been shown
to enhance viral mRNA export in later stages of infection, as well as increase viral mRNA
translation, it has also been shown inhibit cellular mRNA export (reviewed in 30, 31). The
functions of each influenza A protein are summarized in Table 1.
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The mRNAs of the M and NS segments are each spliced to generate the M2 and
NEP/NS2 proteins, respectively. Additionally, an 11th protein, PB1-F2 is encoded in an
alternate open reading frame near the 5’ end of PB1. This protein is not present in all
influenza A virus strains but has been shown to contribute to virulence in mammals (32, 33).
PB1-F2 was suggested to have pro-apoptotic activity during infection by killing host immune
cells responding to infection with A/Puerto Rico/8/1934 (PR8) (29, 34, 35). Further research
found that the pro-apoptotic activity was restricted to the laboratory strain, PR8, but the PB1F2 protein of the three pandemic influenza strains during the 20th century, as well as an HPAI
H5N1 subtype, functions to enhance the lung inflammatory response and induces increased
pathology in a mouse model. McAuley et al. suggest this additional protein increases the
virulence of pandemic strains when the PB1 segment is derived from an avian influenza
strain (33).

Influenza A virus replication
Replication of influenza viruses begins with attachment to host cells expressing
specific receptors. It has been shown that the surface glycoproteins bind to neuraminic acids
(e.g., sialic acids) on the cell’s surface to initiate infection and replication. Generally, human
influenza viruses preferentially bind to an N-acetylneuraminic acid that is attached to the
ending galactose sugar by an 2,6 linkage (SA2,6Gal) commonly found in the upper
respiratory tract while avian influenza viruses preferentially attach to sialic acids with an
2,3 linkage which are found in the lower respiratory tract of humans (36). While human
influenza virus receptors(Saα2,6Gal) are prominent in the respiratory tract and lungs,
receptors for avian influenza (SA2,3Gal) have been found on type II pneumocytes, bronchi,
bronchioli, trachea, a few epithelial cells in the upper respiratory tract, and cells outside the
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respiratory tract, Kupferr cells, glomerular cells, splenic T cells, and neurons in the brain and
intestine (37). The absence of avian influenza receptors in the upper airway could explain the
lack of efficient human-to-human transmission of H5N1.
After attachment to the host cell, influenza virus is internalized into endocytic
compartments via clathrin-mediated endocytosis (38) or nonclathrin, noncaveoliae-mediated
endocytosis (39). The viral HA undergoes a structural change after the HA0 precursor is
cleaved into HA1 and HA2. It has been suggested that the cleavage of human influenza virus
HA proteins is completed by type II transmembrane serine proteases and human airway
trypsin-like protease. HPAI viruses, however, do not require these specific proteases and the
HA protein can be cleaved by ubiquitously expressed subtilisin-like proteases (reviewed in
40). Several cleaved HA molecules undergoing conformational changes in the acidic
environment of the endosome results in uncoating and releasing contents of the virion into
the cytoplasm (41). The first few steps of the viral replication cycle occur quickly with the
majority of virus particles entering the cytoplasm from the endosome about 25 minutes after
internalization and RNP complexes reaching the nucleus only ten minutes later (42).
The viral RNP (vRNP) consists of viral RNA, which is coated by NP and has the
PB1, PB2, and PA proteins bound to the partially complementary ends of the viral RNA. The
vRNP enters the nucleus where viral RNA synthesis occurs. The vRNPs are too large for
passive diffusion and use active nuclear import mechanisms of the cell to reach the nucleus.
While all proteins in the vRNP have nuclear localization signals, it has been shown that the
signals on the NP are both sufficient and necessary for viral RNA import into the nucleus
(29).
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Once the negative sense viral RNA is imported into the nucleus, replication occurs
following a two-step process. A full-length positive-sense copy, termed complementary RNA
(cRNA), of the viral RNA is made from the negative sense strand. The cRNA is used as a
template to generate more viral genomic RNA. Additionally, the negative sense viral RNA is
also transcribed into viral messenger RNA (mRNA) by a primer-dependent mechanism. The
mRNA are not full copies of the viral RNA and are capped and polyadenylated. The reaction
of viral RNA to mRNA, viral RNA to cRNA, and cRNA to viral RNA are all catalyzed by
the same RNA-dependent RNA polymerase (RdRp) complex comprised of the influenza
PB1, PB2, and PA proteins and is packaged within the virion (29).
Influenza RdRp is used to replicate the viral genome and transcribe its mRNA.
Through a process known as “cap-snatching,” a 5’ capped primer is taken from host premRNA transcripts and used to initiate mRNA synthesis (43, 44). The same polymerase used
for transcription is used for polyadenylation of the mRNA transcripts. A stretch of five to
seven uracil residues and an adjacent double-stranded region of the viral RNA promoter are
required for polyadenylation (45-47). In addition to translation of eight influenza proteins
from the eight mRNAs generated through transcription, the translation of M and NS mRNA
can result in two proteins each due to splicing (i.e., M1 and M2, and NS1 and NEP/NS2,
respectively) (29).
In addition to acting as a template for mRNA synthesis, viral RNA is also used as a
template for cRNA, which is full length and is not capped or polyadenylated. The RdRp used
for mRNA synthesis in a primer-dependent manner is also used to generate cRNA
independent of a primer (29, 44, 48). Soon after the virion contents are released and imported
to the nucleus, the RNPs are only capable of transcription (29). If the process is interrupted at
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this step, there will be an accumulation of mRNA in the cell. The switch from mRNA
synthesis to cRNA synthesis is not fully understood and several hypotheses have been
suggested (29, 44, 48). One hypothesis is that an accumulation of NP is required to produce
full-length cRNA, which only occurs after translation (29). An alternate model is that a
switch does not occur, but NP and the polymerase have a stabilization role and both mRNA
and cRNA are made early during infection but cRNA is degraded until enough NP exists to
encapsidate the cRNA (48). More recently, it has been shown that the concentrations of
capped cellular mRNA, the 5’-end of the viral RNA, and the RdRp regulate the switch
between transcription and replication (44).
Once copied viral RNA has been synthesized from cRNA, it must be exported from
the nucleus. However, before export to the cytoplasm, the newly generated viral RNA must
be encapsidated by NP and form an RNP complex with PB1, PB2, and PA. These complexes
are then exported through the functions of M1 and NEP/NS2. The M1 protein has been
shown to associate with the lipid membrane and interact with vRNP and NEP/NS2.
Following export to the cytoplasm, influenza viruses are packaged and assembled at the
apical plasma membrane of polarized cells where they can bud out of the host cell. Budding
will not occur in the absence of M1. Additionally, once the virus particle buds from the cell,
its envelope remains attached to the cell membrane and NA is required to remove the sialic
acid from the carbohydrate to complete the budding process. Without NA, the particle cannot
be released from the cell (29).

Highly pathogenic avian influenza in humans
Birds are the reservoir for influenza A viruses with three subtypes having emerged in
humans as pandemic strains: H1N1 (1918 and 2009), H2N2 (1957), and H3N2 (1968) (49).
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Generally, influenza viruses are species-specific and inter-species transmission is not
common. However, some avian influenza viruses have been shown to jump the species
barrier and infect other mammals such as horses (50), pigs (51), and whales (52) without
reassortment with circulating human influenza strains. The influenza strains that caused the
1957 and 1968 human pandemics were reassortant strains of both human and avian viruses
believed to have been generated in pigs. Reassortant strains can arise when a host, such as a
pig, acquires two or more influenza strains concurrently. Following replication of multiple
strains, progeny virions can contain segments from one or more strain of influenza and
continue to spread among new hosts (28).
An avian influenza H5N1 not previously known to infect humans infected eighteen
people in Hong Kong between May and December of 1997. The first case was a previously
healthy three-year-old boy who was hospitalized six days after the onset of fever, sore throat,
and cough, and died six days after hospitalization. Death was attributed to acute respiratory
distress secondary to viral pneumonia, multi-organ failure, disseminated intravascular
coagulation, and complications from Reye’s syndrome (9, 53). The second case was a twoyear-old boy with congenital heart disease that presented with the same symptoms, was
hospitalized, and survived. Subsequent cases included previously healthy individuals ranging
in age from 1 to 60 years old who presented with typical flu-like symptoms as well as
vomiting in one case (9). H5N1 influenza virus was isolated or seroconversion to H5N1 virus
was detected by a neutralization assay in each of the confirmed cases. Overall, 18 individuals
were confirmed to have H5N1 infection in 1997 and six cases were fatal (33%) (8, 9, 54, 55).
Following the initial avian influenza outbreak in humans, an epidemiological
investigation was performed with serum samples from 502 people who may have had contact
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with the initial case or with poultry. Samples included serum from family members,
neighbors, children and staff of the child-care center, health-care workers, poultry workers,
and workers on pig farms. Control samples from 218 healthy children and 201 healthy adult
residents of Hong Kong were also collected. All serum samples were tested for antibody to
H5N1 using micro-neutralization assays. Of the 502 samples, 9 (2%) had elevated titers
suggesting they were exposed to H5N1 though they may have been asymptomatic. The
positive results included 5 poultry workers, and 1 each from the health care workers,
neighbors, lab workers, and child care center contacts. The remaining samples and all the
control samples were negative (9, 54, 56).
Antigenic and genetic analysis of the viral isolates from seven confirmed cases
indicated two closely related but distinguishable groups of H5N1 suggesting multiple
introductions in humans from poultry sources. Genetic reassortment between avian and
human influenza viruses likely did not occur since all eight RNA genomic segments were
from an avian virus (9, 54, 56).
The first case of H5N1 infection in humans in 1997 was determined to be the result of
direct exposure to infected poultry (57). More recent patients however, fell ill following
plucking and preparing diseased birds, handling fighting cocks, playing with infected poultry,
and consuming undercooked infected poultry (58). While human-to-human contact is not
common, there have been isolated reports of limited household clusters of infection (59) and
a case of child-to-mother transmission (60). Serologic studies of health care workers and
social contacts of infected humans suggested inefficient transmission (61) although further
studies with RT-PCR detected mild cases, more infection in older adults, and more clusters in
families in Vietnam causing concern that H5N1 may be adapting to humans (58).
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Following the initial outbreak of H5N1 in humans in 1997, H5N1 did not appear
again in humans until its re-emergence in 2003 (17, 62-64). The first new cases of avian
influenza infection were confirmed in a family of five that had visited mainland China where
they had contact with live chickens. Three members of the family (ages 7, 8, and 33) became
ill and the previously healthy 7 year old and 33 year old died of the disease. The 8 year old
recovered and was confirmed to also have been infected with influenza A, subtype H5N1
(17).
Generally, HPAI presents in healthy young children or adults and presentation of
initial symptoms include: high fever and “influenza-like” illness with lower respiratory tract
symptoms (58). Some patients also experienced diarrhea, vomiting, abdominal pain, pleuritic
pain, and bleeding from the nose and gums (59, 65-67). Atypically, patients presented with
encephalopathy and diarrhea in the absence of respiratory symptoms (68). Illness
presentation began with lower respiratory tract manifestations and respiratory distress,
tachypnea, and inspiratory crackles (66). Pneumonia was apparent in nearly all patients and
radiographic abnormalities were observed at a median of seven days following fever onset
(66). The illnesses progressed to respiratory failure and acute respiratory distress syndrome
(ARDS) manifested around six days after illness onset (66). Additionally, multi-organ failure
with signs of renal dysfunction and cardiac compromise (59, 65-67) were also common as
well as pulmonary hemorrhage, pneumothorax, pancytopenia, Reye’s syndrome, ventilatorassociated pneumonia, and sepsis syndrome without bacteremia (58).
As of January 2013, the WHO reported the fatality rate among hospitalized patients to
be approximately 59% (23). It is important to note that the 59% fatality rate may be accurate
only for patients who are hospitalized and may not account for individuals who are infected
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with H5N1 although asymptomatic or who have only a mild illness and do not seek medical
attention. A seroprevalence study of H5N1 infection in humans showed that 1 to 2% of more
than 12,500 individuals in 20 separate studies had seroevidence for H5N1 infection
suggesting that H5N1 infects more humans than are reported (69). While the initial
emergence of H5N1 in humans in 1997 resulted in most deaths among patients older than 13,
more recent H5N1 strains have resulted in a case fatality rate of 89% in patients younger than
15 and increased fatalities in infants and young children (59, 66). This fast progressing
disease results in death nine to ten days following illness onset with progressive respiratory
failure as the cause of death (58, 59, 66).
Although H5N1 has continued to diversify since the H5 hemagglutinin gene was
sequenced in 1997, the HA has remained relatively unchanged providing a basis for
comparing emerging strains. This has also permitted the development of a standard
nomenclature system based on clades that group H5 isolates by their HA sequence (70). This
system has formally identified 20 distinct clades of virus since 2008 (71, 72) and clades are
defined by an isolate meeting these specific criteria: 1) share a common clade-defining node
in the phylogenetic tree, 2) the grouping is monophyletic with a bootstrap of > 60 at the node
(after 1000 neighbor-joining bootstrap replicates, and 3) the average percentage pair-wise
nucleotide distances between and within clades of > 1.5% and < 1.5% respectively. Sublineages, or sub-clades, are added as the viruses evolve within these identified clades until
they meet the three criteria for forming a new clade. While 20 clades have been identified, 13
of these have been considered inactive and have not been detected since 2008 (70). The
eradication of the 13 strains could have been the result of being out-competed by other
emerging strains or high mortality in the host and thereby prohibiting efficient spread.
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HPAI pathogenesis in animal models of infection
Experimental infections of influenza A virus in animal models are often used to study
virus characteristics and pathogenesis as well as the host immune response. The mouse
model is commonly used to study infectious diseases and has been used to elucidate the
pathogenesis of H5N1. Unlike human influenza A viruses, avian influenza A viruses such as
H5N1 can replicate in the mouse without requiring prior adaptation (73-75). In mice, H5N1
viruses are classified as either lethal (A/HongKong/483/1997-like) or nonlethal
(A/HongKong/486/1997-like). H5N1 viruses that are “HK483-like” result in systemic
spread, cytokine dysregulation, severe tissue pathology, and death. Conversely, infection
with an “HK486-like” virus results in replication limited to the respiratory tract, and mice
cleared the virus 7-9 days post-infection (74, 76). Research with these two viruses suggests
that differences in inflammatory and innate immune responses may be the mechanism of
increased pathogenesis of the “HK483-like” viruses (74, 76). Specifically, infection with a
lethal virus results in a significant reduction of circulating lymphocytes (74, 77) and an
increase in apoptosis in the lung and spleen compared with less virulent strains (74).
Interestingly, H5N1 has been shown to spread to the brain of infected mice and this
characteristic also separates “HK483-like” viruses from “HK486-like” viruses (74, 78, 79).
Similar to what was observed in the lung, the innate immune response in the central nervous
system (CNS) also differentiated virulent from non-virulent strains of H5N1. The lethal
strains resulted in the synthesis of pro-inflammatory cytokines in the brain, which resulted in
anorexia, weight loss, and death (80). Viruses isolated from later outbreaks in 2004, can also
be characterized as highly virulent or lowly virulent with infection of highly virulent strains
resulting in systemic spread in mice (81). Unlike the strains isolated in 1997, which required
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high inoculating doses to induce lethality, Maines et al. demonstrated 20-60 infectious
virions were sufficient to cause lethality in BALB/c mice with an isolate from 2004 (81).
HK483 has been shown to result in higher neurotropism than other 1997 isolates of
H5N1 (82) and has been used to identify routes of infection in the CNS (78). Following
intranasal inoculation of 104 LD50 of HK483, BALB/cA Jcl mice were examined one to six
days post-infection and immunohistochemistry (IHC) and in situ hybridization were used to
detect viral infection in the brain. Virus was detected in the nasal cavity as early as one day
post-infection and in the lung by two days post-infection. The first detection of virus in the
CNS was in the pterygopalatine ganglia, trigeminal ganglia, and spinal cord at three days
post-infection. By five days post-infection, virus was detected in the olfactory bulb,
cerebrum, brain stem, and vagal ganglia in addition to the nasal cavity and lung. The in situ
hybridization results were similar to the IHC results for both tissue and day of detection for
the CNS (78).
While mice are often used to study infectious diseases, ferrets have become a
standard for studying the pathogenesis of influenza viruses due their ability to closely model
influenza infection in humans. Ferrets sneeze, cough, experience fever and nasal discharge,
as well as become lethargic (reviewed in 83). The similarities in pathogenesis and viral
distribution may be due to the sialic acid distribution in their respiratory tract, which is
similar to that in humans. Both ferrets and humans have predominantly (2-6)-linked sialic
acids on the upper airway epithelia and (2-3)-linked sialic acids on the lower airway
epithelia (83).
In contrast to the mouse model, the dichotomy of “HK483-like” and “HK486-like”
viruses is not valid in the ferret model of HPAI infection (75, 84). In ferrets, infection with
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either of these viruses results in disease that includes lethargy, clinical signs of respiratory
disease, weight loss, lymphopenia, and at high doses, neurological signs (85). Both of these
H5N1 isolates from 1997 can spread systemically in ferrets reaching the spleen, intestine,
liver, and peripheral blood (81).
H5N1 isolates from the 2004 outbreak have also been used to study pathogenesis in
the ferret model, and similar to what was observed in mice, these strains exhibit increased
virulence compared to strains isolated in 1997 (81, 86). These isolates, that include
A/Vietnam/1203/2004 (VN1203) and A/Thailand/16/2004 (Thai16) routinely spread to the
brain, spleen, and intestine and resulted in a faster mean time-to-death when compared with
H5N1 isolates from 1997 (81). Additionally, increased inflammation was observed in the
brains of ferrets infected with the 2004 isolates, as was diffuse interstitial inflammation in the
lungs (81, 86). Wang and colleagues found that VN1203 infection in ferrets could be
characterized by high viral titers in the brain and low levels in the ileum using real-time PCR.
Importantly, they found that viral RNA could be detected in the blood one to two days postinfection suggesting viremia could be an important marker of fatal infection in ferrets (87).
HPAI H5N1 preferentially attaches to nonciliated cuboidal epithelial cells, type II
pneumocytes, and alveolar macrophages. It rarely attaches to the upper respiratory tract and
most often results in lesions in the alveoli and bronchioles, not in the trachea or bronchi
(reviewed in 88). Additionally, H5N1 has been found in human brain, intestine, liver, lymph
nodes, placenta, and fetal lung and it is believed to be spread systemically by viremia (88) or
via the peripheral nervous system (89).
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Viral determinants of increased pathogenesis of HPAI
Since the emergence of H5N1 in humans in 1997, HPAI has been widely studied to
identify virulence mechanisms that contribute to increased pathogenesis and lethality in
humans as well as identify markers of possible human-to-human transmission. The HA0 of
influenza viruses must be cleaved post-translationally into the subunits HA1 and HA2 at a
conserved arginine residue for infectivity to occur through the activation of the membrane
fusion potential of HA (90). Research on H5N1 strains isolated in 1997 identified a multibasic cleavage site present on the HPAI HA that permitted the cleavage to be activated by
multiple intracellular proteases, including furin-like proteases that are ubiquitously
expressed. This is in contrast to the presence of a single cleavage site common in human
influenza strains that require extracellular trypsin-like proteases to cleave the HA0 into HA1
and HA2 (91-93). It subsequently has been shown that removal of the multi-basic amino acid
cleavage site reduces virulence (94); however, the possession of the site is not sufficient for
virulence since not all H5 or H7 viruses with this sequence are lethal in mammals (74, 81,
95). This multi-basic cleavage site has also been shown to be essential in the systemic spread
of H5N1 along the olfactory and hematogenous routes in ferrets (96).
Neuraminidase (NA) is a glycoprotein in addition to HA that is present on the surface
of influenza virus particles and is essential for release of the virus particle during the budding
process following replication. The anti-influenza agents zanamivir and oseltamivir block the
NA from cleaving the sialic acid residues and therefore inhibit the progeny virions from
budding (97). Wagner et al. revealed a correlation between the avidity of HA and the
strength of NA activity. When HA exhibits weak binding, the NA is likely to have weakened
activity (98, 99). Importantly, it has been shown that when the active sites of these proteins
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are mutated, the binding activities are altered and insertions and deletions in the NA stalk
regions that alter its length can modify its activity (100, 101). Specifically, NA stalk
deletions prominent in H5N1 viruses increase virulence in the mouse model (102). While
virulence determinants have been identified in the HA and NA of H5N1 viruses, these
glycoproteins are not the only determinants of pathogenicity. Experimentally generated
reassortant viruses containing the HA and NA from virulent HPAI strains with the remaining
six genes from non-virulent influenza viruses were not lethal to mice or ferrets (77, 103).
Subsequent to fusion of the virus to the host cell, the ion channel activity of matrix 2
(M2), an integral membrane protein, induces the virus to dissociate the ribonucleoprotein
(RNP) complex from the virus. Additional roles of the M2 protein include assembly,
budding, and the ratio of filamentous and spherical particles (104-106). This protein is highly
conserved and is believed to be a good target for developing a universal influenza vaccine
(107). The antiviral medicines amantadine and rimantidine target the influenza A M2 protein
to inhibit viral uncoating or disassembly of the virion during endocytosis. New antiviral
treatments need to be developed because influenza A viruses have now acquired resistance to
amantadine through mutations in the M2 segment (108, 109).
Experimentally generated reassortant viruses have been used to demonstrate the role
of the polymerase complex (PB1, PB2, and PA) in pathogenesis and increased virulence (77,
103). The replacement of these genes in A/Ck/Vietnam/C58/04, a non-virulent strain, with
the PB1, PB2, and PA of A/Vietnam/1203/2004, a highly virulent influenza strain, resulted in
increased virulence. Conversely, the PB1, PB2, and PA of A/Ck/Vietnam/C58/04 inserted in
the A/Vietnam/1203/2004 backbone resulted in an attenuated virus that abolished the
increased pathogenicity in mice and ferrets (103). The importance of the polymerase
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complex was also shown by inserting the PB1, PB2, and PA of a human H3N2 virus into the
backbone of a HPAI H5N1 which resulted in efficient replication but poor transmission (77).
This suggests viral replication may be a key determinant of lethality and these proteins
should be examined further for their role in virulence.

Genetic analysis of A/Vietnam/1203/2004 and A/HongKong/483/1997
The clade 0, A/HongKong/483/1997 (HK483) and clade 1 virus,
A/Vietnam/1203/2004 (VN1203) are often compared to elucidate novel virulence factors
through genetic analysis, reverse genetics techniques, and animal studies to compare
differences in the pathogenesis of these distinct viruses. Both viruses were isolated from fatal
human cases; however, they have been shown to have differing lethality in animal models
with VN1203 exhibiting 100% lethality in ferrets and HK483 resulting in up to 33% lethality
(81). A multiple sequence alignment of the ten proteins encoded by the VN1203 and HK483
genomes identified the NS1 segment as the most different (19% different) between these two
strains while the remaining nine proteins were only 2.2-9.5% different (Table 2).
Interestingly, both HK483 and VN1203 contain the multi-basic amino acid cleavage
site in the HA and both lack the E158G mutation in PB2 that has been shown to confer
virulence. Not surprisingly, neither virus possesses the D701N mutation in PB2 that enhances
transmission (110).

Neuropathogenesis of influenza A
Influenza is often considered to cause disease in the respiratory tract; however there
has been evidence of CNS involvement in twelve influenza A pandemics or epidemics over
the last century (1). The neurological sequelae have not been extensively studied and the

17

recurrence of these symptoms with each pandemic should be considered when studying
newly emergent influenza strains such as HPAI H5N1.
Case reports from the 1918 “Spanish Influenza,” which was caused by an H1N1 virus
that contained avian influenza segments, describe the frequent observation of delirium –
sudden severe confusion and rapid changes in brain function - despite the absence of
meningitis (111). Post-mortem examination of the CNS revealed several cases where
degeneration was observed in nerve cells, particularly in the motor nuclei in the pons.
General congestion of the brain was also found; however, inflammation was not observed in
the brain or meninges (112). In addition to acute effects of influenza on the CNS during the
1918 pandemic, long-term (6 to 12 months) effects in patients that recovered were also
described as follows: depression, neurasthenia – weakness in the nerves, fatigue, anxiety,
depression, and headache, neuritis – inflammation in the nerves, impaired sensation, strength,
and reflexes, abnormal circulation, inability to sweat, and other “nervous ills.” Researchers at
the time hypothesized that the pandemic strain specifically infected nerve centers and
justified it by the clear and extensive neurological sequelae. They also speculated the
pneumogastric nerve (now commonly referred to as the vagus nerve) was the origin due to
the complications principally involving the stomach and lung (113). Other instances of
neurological involvement following the 1918 pandemic included cerebro-spinal fever,
poliomyelitis, and polio-encephalitis (114). Finally, a link between encephalitis lethargica –
high fever, ophthalmoplegia, mental confusion, and lethargy – during influenza infection and
post-encephalitic Parkinsonism was described (reviewed in 1).
The H1N1 influenza strain that caused the 1918 pandemic was not the only subtype to
induce neurological manifestations of disease. The H2N2 pandemic in 1957 consisted of
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reported cases of encephalitis, seizures, muscle paralysis, and Guillain-Barré-like syndrome
(1, 115) and the H3N2 pandemic in 1968 had reported cases of amyotrophy, flares of
multiple sclerosis, encephalitis, encephalopathy, myelopathy, polyneuropathy, and GuillainBarré-like syndrome. During the 1968 pandemic however, one researcher suggested the
encephalitis was not due to viral infection but due to fulminating staphylococcal septicemia
(116).
The most recent pandemic in 2009 as a result of the novel swine origin H1N1 strain
of influenza also caused neurological sequelae in infected individuals. A study of primary
neurological manifestations of 2009 H1N1 in California were described as
encephalopathy/encephalitis, seizures, meningitis, and “other” which referred to one case of
Guillain-Barré Syndrome. The study examined 2,069 cases of severe or fatal 2009 H1N1
infections and found neurological signs in 20% of the confirmed cases with 18% of those
(~4% of the total) described as “primary influenza-associated neurological complications”
and the remainder as secondary neurologic manifestations (117).
Neurotropism of avian influenza has been described in naturally susceptible
populations of avian species (118, 119) as well as in mammalian species such as domestic
cats, tigers, leopards, mice, and others (52, 119-121). CNS involvement of H5N1 is not
limited to avian species and other animals, as it has been described in humans as presentation
of encephalitis or encephalopathy and found more often in children than adults (3). In
humans, H5N1 has been detected in the brain and cerebrospinal fluid of some patients
following clinical presentation of diarrhea, generalized convulsions, seizures, and coma (3,
24, 68, 88, 121-123). The occurrence of symptoms outside the respiratory tract suggests
avian H5N1 has a wider tissue tropism than human influenza viruses. Unfortunately, in most
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cases, limited autopsy samples were taken and viral replication could not be confirmed in
extra-pulmonary tissue (84). In 2005, post-mortem tissue from a fetus and two adult patients
that succumbed to H5N1 infection were examined to better understand the pathogenesis of
the virus. Viral genomic sequences and antigen were detected in many extra-pulmonary
tissues including neurons of the brain. The presence of virus in the brain was confirmed by
in-situ hybridization and immunohistochemistry (24). A more detailed study also found
H5N1 virus in the brain of a patient in 2008 with a history of fever, cough, and dyspnea.
Virus was successfully isolated from the cerebral cortex, cerebral medullary substance,
cerebellum, brain stem, hippocampus ileum, and other organs outside the respiratory tract
(123). These findings suggest H5N1 is reaching the CNS and replicating to high titers
following natural infection. More research must be conducted to further explore the route of
infection and identify targets to prevent dissemination to the CNS.
Early animal studies after the initial H5N1 outbreak in 1997 sought to characterize
the newly emerging strains and found that H5N1, specifically in mice and ferrets intranasally
infected with high doses of HK483, could replicate in the brain and cause neurological signs
of infection. HK483 was highly lethal in mice, with 100% mortality but lesser so in ferrets at
only 5-10% (84). More recently, other strains of H5N1 have also been shown to replicate in
the brain of ferrets and result in high lethality suggesting H5N1 does have a wider tropism
compared with circulating human influenza strains. Furthermore, they are able to induce
severe CNS involvement and lethality in mammals (24, 86, 88, 89, 121-125).

Purpose of study
Increased understanding of neurotropism and clinical signs of CNS involvement may
aid clinicians in the earlier diagnosis of H5N1 infection when patients present with atypical
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symptoms. Further studies to elucidate the molecular determinants of neurotropism as they
contribute to increased lethality could guide development for therapeutics and vaccines that
could target aspects that prevent the virus from entering the brain and increasing the
mortality rate compared to virus strains that do not reach the CNS.
Preliminary studies in our laboratory and literature reports of neuropathogenesis in
mammals suggest H5N1 viruses that disseminate to the brain and replicate in neuronal tissue
are more lethal than those confined to the respiratory tract. The studies presented here use the
ferret model to examine differences in the neuropathogenesis of HK483 and VN1203
(Chapter 2) and differences between CNS involvement following intranasal instillation and
aerosol exposure of VN1203 (Chapter 3).
The ferret model is often used to study the pathogenesis of H5N1 virus and is a good
comparison for pathogenesis in humans. While intranasal instillation is the common method
of infection in ferrets, the use of nose-only aerosol chambers have recently been introduced
as a better model for presenting H5N1 in a more physiologically relevant manner (126, 127).
This dissertation includes the results of two original studies that specifically examine the
neuropathogenesis of two H5N1 viruses from different clades following intranasal instillation
and aerosol exposure to physiologically relevant low doses of H5N1. The first virus, HK483
was isolated during the initial outbreak of H5N1 in 1997 and has been shown to have less
lethality than a strain isolated in 2004, VN1203. HK483 and VN1203 are often used to
compare differences in pathogenesis to determine viral determinants of lethality (81, 85).
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Figure
Figure 1. Cartoon representation of an influenza virus.
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Tables
Table 1. Influenza RNA segments and known functions of each translated protein.
RNA segments/proteins

RNA genome length
(in nucleotides)

Protein length
(in amino acids)

PB2

2341

759

PB1-F2

87

PB1

2341

757

PA

2233

716

HA

1778

550

NP

1565

498

NA

1413

454

M1

1027

252

M2

366

97

NS1

890

230

NEP/NS2

418

121

34

Function
Cap recognition, component of
the RNA transcriptase complex
Pro-apoptotic activity
Endonuclease activity,
elongation, part of transcriptase
complex
Protease, part of transcriptase and
replicase complex
Surface glycoprotein, receptor
binding, fusion activity, major
antigen
RNA binding, RNA synthesis,
RNA nuclear import
Surface glycoprotein,
neuraminidase activity
Matrix protein, interaction with
vRNPs and surface
glycoproteins, nuclear export,
budding
Membrane protein, ion channel
activity, assembly
Multi-functional protein, viral
interferon antagonist
Nuclear export of vRNPs

Table 2. Genetic analysis of VN1203 and HK483.
Segment Protein
1
PB2
2
PB1
3
PA
4
HA
5
NP
6
NA
M1
7
M2
NS1
8
NS2
a.a.: amino acid

# a.a.
759
684
716
568
498
450
252
97
230

# Same a.a.
733
669
669
546
487
407
240
88
186

# Different a.a.
26
15
32
22
11
43
12
9
44

121

110

11
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Percent
Similarity
97%
98%
93%
96%
98%
90%
95%
91%
81%
91%
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Abstract
Highly pathogenic avian influenza A (HPAI), subtype H5N1, remains an emergent threat to
the human population. While respiratory disease is a hallmark of influenza infection, H5N1
has a high incidence of neurological sequelae in many animal species and sporadically in
humans. We elucidate the temporal/spatial infection of H5N1 in the brain of ferrets following
a low dose, intranasal infection of two HPAI strains of varying neurovirulence and lethality.
A/Vietnam/1203/2004 (VN1203) induced mortality in 100% of infected ferrets while
A/Hong Kong/483/1997 (HK483) induced lethality in only 20% of ferrets with death
occurring significantly later following infection. Neurological signs were prominent in
VN1203 infection, but not HK483, with seizures observed three days post challenge and
torticollis or paresis at later time points. VN1203 and HK483 replication kinetics were
similar in primary differentiated ferret nasal turbinate cells and similar viral titers were
measured in the nasal turbinates of infected ferrets. Pulmonary viral titers were not different
between strains and pathological findings in the lungs were similar in severity. VN1203
replicated to high titers in the olfactory bulb, cerebral cortex, and brain stem; whereas HK483
was not recovered in these tissues. VN1203 was identified adjacent to and within the
olfactory nerve tract and multifocal infection was observed throughout the frontal cortex and
cerebrum. VN1203 was also detected throughout the cerebellum, specifically in Purkinje
cells and regions that coordinate voluntary movements. These findings suggest the increased
lethality of VN1203 in ferrets is due to increased replication in brain regions important in
higher order function and explains the neurological signs observed during H5N1
neurovirulence.
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Introduction
Highly pathogenic avian influenza A (HPAI), subtype H5N1, has infected humans in
12 countries and has been associated with approximately a 60% mortality rate since 1997
(http://www.who.int/influenza/human_animal_interface/EN_GIP_20111010CumulativeNum
berH5N1cases.pdf). Severe disease of H5N1 includes fast-progressing pneumonia, acute
respiratory distress syndrome (ARDS), diarrhea, central nervous system (CNS) clinical signs,
and multi-organ failure. Death often occurs within ten days of symptom onset (1-3). Studies
to identify virulence factors contributing to these phenotypes have been the focus of many
recent investigations (4-8). However the mechanisms leading to increased pathogenesis by
H5N1, particularly non-pulmonary events, remain to be discovered.
ARDS is a common manifestation of pulmonary influenza infection; however H5N1
has been atypically shown to also infect and damage the CNS. De Jong and colleagues
reported acute encephalitis in brains of humans infected with H5N1. These patients did not
present with respiratory illness but had severe diarrhea, with early onset of seizures and
coma, and death occurring within one to five days post hospital admittance (9). Murine
infection models have illustrated that neurotropic H5N1 strains exhibit higher lethality than
those that do not replicate efficiently in the brain (10). Several groups have investigated
possible routes of viral entry into the brain, including the olfactory system as a major route
into the brain of experimentally infected ferrets (10-12). Studies by Park et al. suggested that,
in addition to the olfactory nerves, HPAI enters the CNS through the vagal, trigeminal, and
sympathetic nerves (12). Furthermore, the dissemination of H5N1 through the bloodstream is
plausible due to the presence of virus in organs such as the spleen apart from the site of initial
infection.
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While these possible routes of infection in the brain have been identified, little is
known regarding HPAI dissemination within the CNS and its contribution to clinical signs
and lethality. Therefore, delineating neurotropic features of H5N1 infection in the ferret
model could lead to a better understanding of mechanisms responsible for widespread
infection throughout the central nervous system.
Herein, we compare two strains of H5N1 with distinct neurotropism and lethality in
ferrets to elucidate the temporal-spatial neuroinvasion leading to death. We show that
VN1203 resulted in wider dissemination in the brain and associated with higher morbidity
and clinical signs of neurological involvement. By comparison, HK483 infection resulted in
low mortality, no viable virus recovered from the brain, and a low incidence of brain lesions
limited solely to the olfactory system. Furthermore, we identify brain regions and cell types
susceptible to VN1203 that explain the myriad of neurological signs during lethal infection.
These findings broaden our understanding of the neurovirulence of H5N1 viruses and support
further investigation into therapies leading to CNS protection.

Materials and Methods
Ethics statement
The protocol (FY10-098) for all animal procedures was approved by the Institutional
Animal Care and Use Committee (IACUC) and Institutional Biosafety Committee of the
Lovelace Respiratory Research Institute, Albuquerque, NM. All facilities were accredited by
the Association for Assessment and Accreditation of Laboratory Animal Care International
(AAALAC). Ferret experiments were conducted in the Animal Biosafety Level 3 enhanced
(ABSL-3+) facility and guidelines for ferret housing, environment, and comfort described in
the Guide For The Care and Use of Laboratory Animals, Seventh Edition, National Research
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Council, were strictly followed. Euthanasia was performed under the guidance of the
American Veterinary Medical Associations (AVMA) Guidelines on Euthanasia.
Virus preparation
Highly pathogenic avian influenza A (HPAI) H5N1 viruses were obtained from the
Centers for Disease Control and Prevention (CDC) (Atlanta, GA). A/Vietnam/1203/2004
(VN1203) was isolated from a pharyngeal swab from a ten year old male patient that died of
the disease in Vietnam in 2004 (7) and A/Hong Kong/483/1997 (HK483) was isolated from a
13 year old male patient that died of the disease in Hong Kong in 1997 (7). These viruses
were propagated from the CDC stock in eggs twice to produce working stocks, aliquoted,
titrated by plaque assay on Madin-Darby Canine Kidney (MDCK) cells, and stored at -80C.
All manipulations with these viruses were conducted under Biosafety Level 3 (BSL-3)
conditions in the BSL-3 or animal BSL-3 enhanced (ABSL-3+) at the Lovelace Respiratory
Research Institute in Albuquerque, New Mexico.
Ferret handling/care and infection
Castrated male ferrets (Mustela putorius furo), 11 – 14 weeks of age at the day of
infection, weighing 0.7 to 1.0 kg, (supplied by Triple F Farms, Sayre, PA) were used for the
studies. They were pre-screened by the supplier for H1 and H3 influenza A and influenza B
seroconversion prior to shipment and similarly screened at LRRI within a week prior to
infection. Ferrets were triple-housed throughout (including 14 days of quarantine and after
viral challenge) in stainless steel cages and in separate BioBubbles® depending on H5N1
strain. Ferrets had access to food and water ad libitum. Temperature and humidity ranged 16
to 22C and 30 to 65% respectively, and the light cycle was 12 hr on and 12 hr off.
Ventilation in the study room was >15 air exchanges per hour. All ferret handlers were

40

vaccinated for circulating seasonal influenza strains and were not permitted to enter ferret
quarters if they exhibited any symptoms of upper or lower respiratory infection.
Viral infection of ferrets
Ferrets were identified by an IPTT-300 Implantable Programmable Temperature and
Identification Transponder; Bio Medic Data Systems, Inc, (BMDS) (Seaford, Delaware).
These chips also provided subcutaneous body temperature data using a BMDS electronic
proximity reader wand (WRS-6007; BMDS). Ferrets were anesthetized with an
intramuscular injection of a ketamine/xylazine cocktail (20mg/kg of ketamine and 2 mg/kg of
xylazine). Ferrets received 0.500 mL of pathogen or allantoic fluid per naris with a total of
1.0 mL delivered. Each subject was held upright for about one minute to ensure retention of
the inoculum. Groups of ten ferrets were instilled with 10 PFU of VN1203 or HK483. An
additional group of 18 ferrets was also infected with 10 PFU of HK483 and groups of six
were sacrificed 4, 6, and 8 days post-infection for examination by virology and
immunohistochemical assays.
Clinical observations were conducted twice daily and included temperature readings
from the BMDS microchip and recording of clinical signs of disease. Study personnel were
trained specifically in ferret handling procedures and the observation and recording of
adverse signs and clinical symptoms in ferrets. Observations were recorded using an
electronic data recording system. The onset, nature, severity, and duration of all visible
changes such as abnormal respiration, excretions, behavioral, and neurological signs (i.e.,
paresis, torticollis, seizures, and paralysis) were recorded as well as any observed coughing,
sneezing, and nasal or ocular discharge. Additionally, an activity score was assigned at each
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observation as follows: (0 = alert and playful, 1 = alert but playful only when stimulated, 2 =
alert but not playful when stimulated, and 3 = neither alert nor playful when stimulated).
Cell culture and infection
Primary differentiated cells were isolated from the nasal turbinates of naïve ferrets
and the protocol was adapted with minor modifications as described previously (13). Cells
were rinsed from the tissue and plated directly onto collagen-coated 100mm tissue culture
dishes. Cells were plated directly onto collagen coated transwell inserts (Corning Inc.,
Lowell, MA) with BEGM plus DMEM (Sigma-Aldrich Co. LLC., St. Louis, MO) media in
the basolateral and apical chambers. Approximately seven days later, the media in the apical
chamber was removed and the cells were maintained under air-liquid interface conditions.
VN1203 and HK483 stocks were diluted in sterile 1X PBS to a multiplicity of infection of
0.001 in 100µL. A volume of 100µl of diluted virus or 1X PBS for control was applied to the
apical surface of the cells and virus was allowed to penetrate the cells for one hour at 37°C
and 5% CO2. Following one hour of incubation, the inoculum was removed and cells were
returned to the incubator until the next collection. The inoculum was titered to determine if
there was a difference in adsorption between the two strains. Approximately 500 FFU/mL
was delivered and 0 FFU/mL was recovered from the HK483 infected wells and an average
of 5 FFU/mL was recovered from the VN1203 infected wells. Apical washes were collected
by adding 200 µL of 1X PBS onto the surface and pipetting five times. This was repeated for
a total collection of 400 µL. Apical washes were stored at -80C until viral titers were
determined by an immunostaining foci-forming assay.
Real-time quantitative PCR analysis
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Approximately 250 mg of ferret tissue was homogenized in 1mL of sterile 1X PBS at
the time of collection and a 0.200 mL aliquot was added to Trizol® for a final volume of
1mL. Viral RNA was extracted using the Qiagen RNeasy kit and the Qiagen Universal Robot
(Qiagen Inc., Valencia, CA). Amplification of the full viral coding sequence was done as
previously described in (14). All assays were repeated in triplicate on the ABI 7300 real-time
PCR system (Applied Biosystems, LifeTechnologies Corp., Carlsbad, CA). The quantitative
PCR results were analyzed with the software provided.
Assay for viral titers
Viral titers from the apical wash of infected primary differentiated nasal turbinate
cells and from ferret tissue homogenates were determined using the immunostaining fociforming assay. Approximately 250 mg tissue sections were removed from the right caudal
hilar, right caudal peripheral, left cranial hilar, and left cranial peripheral lung lobes, right
nasal turbinate, olfactory bulb, cerebral cortex, and brain stem. These tissues were placed in 1
mL of sterile 1X PBS with one 5 mm stainless steel bead and homogenized with a Qiagen
tissuelyser (Qiagen Inc., Valencia, CA) for 2 min at 30 Hz/sec. Viral titers were determined
using the 96 well format previously described in (15). Virus present in the cells was stained
with anti-influenza A antibody, MAB-8251, (Millipore, Billerica, MA), an anti-goat
secondary antibody (Vector Laboratories Inc., Burlingame, CA), and detected with 3-Amino9-ethylcarbazole (AEC) (Sigma-Aldrich Co. LLC., St. Louis, MO). Stained foci were
counted and the titer was reported as foci-forming units per mL (FFU/mL).
Hematoxylin and eosin (H&E) stain and immunohistochemistry of ferret tissue sections
Lungs were inflation fixed at 15 cm of pressure with 10% neutral buffered formalin.
The skull, lung, and brain were fixed in formalin for seven days then changed to 70%
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ethanol. Fixed tissues were embedded in paraffin and tissue sections (4-6 µm) were stained
by H&E for histopathological examination under light microscopy. Immunohistochemical
staining was conducted using standard protocols. Briefly, endogenous peroxidases were
blocked and antigen retrieval was performed using a citrate buffer. Avian influenza
nucleoprotein was detected using IMG-5187A, (IMGENEX, San Diego, CA) (16), a
biotinylated secondary antibody, and the ABC standard and DAB kits for detection (Vector
Laboratories Inc., Burlingame, CA). Images were acquired using the Hamamatsu 2.0
NanoZoomer software (Hamamatsu Corp., Bridgewater, NJ). Histological determinations
were made by a board-certified veterinary pathologist unfamiliar with the study design.
Statistical Analysis
GraphPad Prism 5, software version 5.04 (La Jolla, CA) was used to graph data and
perform statistical analysis. The Kaplan Meier survival curve was used for the survival
analysis, a Student’s t-test was used for comparing two means, and an analysis of variance
(ANOVA) was used for comparing multiple means. Mean + SEM is graphed and p < .05 was
considered statistically significant.

Results
HPAI lethality and clinical signs
The neurotropism of HPAI viruses has been reported in human cases as well as in
experimental animal models (4, 9, 10, 12, 17-21). Despite these reports, the
neuropathogenesis of HPAI is poorly understood. To test the contribution of neurotropism to
the lethality of two HPAI strains, low inoculating titers of A/Hong Kong/483/1997 (HK483)
and A/Vietnam/1203/2004 (VN1203) were delivered by intranasal instillation to naïve ferrets
using a dose of approximately 10 PFU to simulate the low amount of virus likely to be
received in a natural infection. As reported previously, VN1203 is known to cause death at
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lower inoculating titers than HK483 (7) and in this study VN1203 infection resulted in a
significantly earlier median time to death (MTTD = 4 dpi) and 100% mortality (n = 10)
within 6 days post-infection (dpi) whereas infection with 10 PFU of HK483 resulted in only
20% lethality (n = 10) (Figure 1A; Mantel Cox test, p< .0001, MTTD unable to be
determined). Body weight was measured daily in all animals prior to and following infection
(Figure 1B). Mock infected ferrets maintained body weight or increased over the twelve day
study period, while all animals that received either VN1203 or HK483 declined in body
weight. Of animals receiving HK483, survivors and non-survivors exhibited similar declines
in body weight both in timing and magnitude, indicating progressing disease. Importantly,
many ferrets receiving VN1203 succumbed prior to appreciable losses in body weight. There
was no significant difference in weight loss post-infection with either VN1203 or HK483 at
inoculating titers of 10 PFU and the eight surviving HK483 challenged ferrets began to gain
weight by 12 dpi.
To assess clinical signs during infection with the two different strains, cage side
observations were performed twice daily on ferrets following 10 PFU of VN1203 or HK483
infection (n = 10 per group). Seven ferrets instilled with VN1203 developed nasal discharge
3 dpi with 100% presenting nasal discharge by 4 dpi. Similarly, 100% of HK483 infected
ferrets exhibited nasal discharge by 12 dpi with two subjects presenting symptoms as early as
3 dpi. Ocular discharge was noted between 3 and 6 dpi in two ferrets challenged with
VN1203 and four ferrets challenged with HK483. These clinical signs indicated upper
respiratory tract infection in the nose and conjunctiva. Eight of ten ferrets challenged with
VN1203 developed neurological signs with four ferrets observed to have convulsions in the
absence of fever 3 dpi, torticollis observed 5 dpi in one ferret, and paresis of musculoskeletal
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dysfunction noted in three ferrets 6 dpi (Table 1). Of the two HK483 challenged ferrets that
did not survive the study period, one died 6 dpi due to severe influenza-associated
pneumonia and secondary bacterial lung infection as determined by histological examination
and the second was humanely euthanized after losing more than 25% of its initial bodyweight
by 11 dpi. Collectively, these findings indicated that a low dose of VN1203 produced more
neurological signs, earlier time to death, and greater lethality compared to ferrets infected
with HK483 while weight loss and symptoms in the respiratory tract were not key factors in
lethality caused by VN1203.
HPAI infection in ferret nasal turbinates
Numerous reports suggest that virulence may be determined by replication kinetics in
epithelial cells of the respiratory tract (20, 22-26). To determine if increased replication in the
nasal epithelium contributed to the increased lethality of VN1203 in ferrets, primary
differentiated ferret nasal turbinate cells were isolated from naïve ferrets, cultured, and
subsequently infected with each H5N1 strain. In preliminary studies, isolated nasal turbinate
epithelial cells grown at an air-liquid interface developed a characteristic polarized,
pseudostratified morphology and were able to maintain trans-epithelial electrical potential
and an air-liquid barrier for greater than two weeks following culture (data not shown). The
appearance of multiple ciliary axonemes by microscopy and visible production of mucus are
indicative of differentiated cultures similar to normal human bronchial epithelial cells that are
routinely used in this laboratory (Figure 2A). Ferret nasal turbinate cultures were infected at
a multiplicity of infection of 0.001 of VN1203 or HK483 to simulate the low inoculating titer
of H5N1 infected ferrets in vivo. Viral titers were measured from the apical wash at 24, 48,
and 72 hours post infection and infection followed the characteristic replication kinetics
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observed for differentiated pulmonary epithelia as previously published by our group (26).
As shown in Figure 2B, there was no significant difference (ANOVA, F(1,6) = 1.88, p = .22)
in the viral replication of these two HPAI strains, suggesting that increased replication in this
cell type is not a key contributor to pathogenesis in ferrets.
To further assess viral replication in the upper respiratory tract, viral load was
measured in the nasal turbinates of ferrets infected with VN1203 or HK483. Nasal turbinate
tissue was isolated from ferrets undergoing planned necropsies at 4 and 6 dpi and
homogenized for analysis by an immunostaining foci-forming assay. Similar viral titers were
measured in the nasal turbinates of HK483 and VN1203 challenged ferrets at 4 and 6 dpi
(Student’s t-test, p = .42) (Figure 2C). Further examination of viral load in the nasal
turbinates was performed by H5N1-specific qRT-PCR analysis of RNA isolated from
homogenized nasal turbinate tissue. PCR standards of RNA genomic copy numbers were
used to determine the gene copy numbers of infected ferret nasal tissues. Consistent with the
findings from viral titer studies, the viral gene copy number was not different between
VN1203 and HK483 at either 4 or 6 dpi, and indicate that viral load of VN1203 and HK483
are similar in the nasal tissues of ferrets (data not shown).
Tissue sections of formalin-fixed, paraffin-embedded nasal turbinates from VN1203
or HK483 infected ferrets were examined by microscopy for histological changes and
infection with HK483 produced focal areas of ulcerations of nasal epithelium and underlying
tissue (Figure 2E). Ulcerations were observed in approximately 10% of each nasal cavity
examined; whereas ulcerations and erosion was observed in approximately 95% of VN1203
infected nasal cavities. The epithelial barrier remained largely intact though inflammatory
cells infiltrated the underlying stroma. The inflammatory response was more pronounced in
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HK483 infection compared to VN1203 infection where inflammatory cell infiltration was not
frequently observed. The nasal cavity of animals challenged with HK483 and examined 4, 6,
and 8 dpi had fewer areas of ulceration in sensory epithelium, the sinuses, and epithelium
lining the perimeter of the nasal cavity. In VN1203 infection, turbinate tissues showed larger
and more numerous focal regions of epithelial changes (Figure 2F), although areas of normal
appearance were present. Areas of histological changes were observed in more distal nares.
Epithelial disruption and a discontinuous apical layer were characteristic of more severe
regions with a loss of cellularity in the basolateral layer (Figure 2F). The presence of
predominantly neutrophils in the submucosa was noted, as was neutrophil exudates in the
nasal lumen. In HK483 infection, alterations of the nasal turbinates were milder at 4 dpi and
increased by 6 and 8 dpi whereas histopathology of VN1203 were more numerous at 3 and 4
dpi. The distribution and severity of epithelial damage was milder in HK483 compared to
VN1203 at all directly comparable time points. There was a pronounced acute inflammatory
response associated with HK483 infection but was not a prominent feature in VN1203
infection.
Immunohistochemical analysis of influenza A NP (Figure 2H,I) indicated scattered
focal areas of virus antigen detection in the olfactory neuroepithelial cells and in other cells
in the intact epithelium of H5N1 infected ferrets as determined by the brown staining against
the Luxol fast blue counterstain. The distribution and number of sites of virus expression in
the nasal turbinates were variable between animals. Neuroepithelial staining exhibited a
clustered appearance (Figure 2I) and this clustered staining was more apparent with VN1203
than HK483 infected nasal turbinates (Figure 2H).
Pathological observations and viral loads in the lung of HPAI infected ferrets
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To assess the extent of respiratory infection concurrent with the lethality and
neurological signs of infection, viral titers from homogenized lung tissue were determined by
an immunostaining foci-forming assay in ferrets at 4 and 6 days following infection. High
viral titers were measured in the lungs of infected ferrets at 4 and 6 dpi, and viral titers in the
lung were similar between ferrets infected with HK483 or VN1203 (Figure 3A).
Additionally, there was no significant difference in the amount of viral RNA measured in the
lung at 4 and 6 dpi for ferrets infected with either virus (Figure 3B). Consistent with the
findings from nasal tissues, VN1203 and HK483 titers were not different in the lungs of
infected ferrets.
Gross examination of lungs from HK483 or VN1203 infection was examined to
assess infection-mediated lung disease in both HK483 and VN1203 infected ferrets. Large
areas of dark reddish-purple consolidation were observed (Figure 3D,E) as compared to
mock infected ferrets (Figure 3C). To investigate the histopathological changes in the lung
of ferrets infected with VN1203 or HK483, randomized sections from four animals per group
were stained with hematoxylin and eosin (H&E). Ferrets instilled with HK483 had few focal
scattered areas of minimal to mild alveolitis and bronchiolitis on 4 dpi. Low numbers of
epithelial cells detached into the lumen of alveolar spaces and there was infiltration of low
numbers of neutrophils. There were peribronchiolar and scattered areas of alveolar
parenchyma loss and infiltration of moderate numbers of neutrophil and mononuclear
inflammatory cells 6 dpi. Locally extensive areas of bronchiolitis and peribronchiolar
pneumonia, with localized loss of alveolar spaces in some animals were also observed
(Figure 3G). The lung of ferrets challenged with VN1203 had multiple focal areas of
pronounced cytopathology in the alveolar lining epithelium on 3 dpi. The severity of
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epithelial loss and damage to the interalveolar wall resulted in fibrin and edema exudate and
hemorrhage in these areas. There was infiltration of low numbers of neutrophil inflammatory
cells, primarily in the interalveolar wall. Examination of lungs at 6 dpi showed multifocal
areas with moderate neutrophil infiltration in the alveolar walls and alveolar spaces and
minimal to mild edema exudate (Figure 3H). While the type of damage induced by each
strain was distinct, the distribution of lung damage in the airways and alveoli were equivalent
following either VN1203 or HK483 infection in ferrets.
HPAI viral load in the brain
Little is known regarding CNS involvement in the progression of HPAI disease. To
determine the extent to which VN1203 and HK483 replicated in the olfactory bulb, tissue
homogenates of the olfactory bulb were evaluated for viral titers. High viral titers were
measured in the olfactory bulb of ferrets 3 to 6 days post challenge with VN1203. In contrast,
no virus was recovered at 4, 6, or 8 dpi from the olfactory bulb of ferrets infected with
HK483 (Figure 4A). To further assess more distal brain regions, viral titers from the cerebral
cortex were also measured. Titers up to 107 foci forming units (FFU)/mL were detected in the
cerebral cortex of ferrets that died of VN1203 infection while no virus was recovered from
HK483 infected ferrets (Figure 4C) examined at the peak of infection. VN1203 infected
ferrets had approximately 105 FFU/mL in the brain stem and viable virus was below the limit
of detection (1 FFU/mL) in this tissue from ferrets infected with HK483 (Figure 4E).
Typically, VN1203 was found at high levels in all animals at the time of death or euthanasia.
In addition to high titers of viable VN1203 isolated from the brain sections, high copy
numbers of viral RNA were also measured in the olfactory bulb, cerebral cortex, and brain
stem of infected ferrets 3 to 6 days post challenge. Viral RNA copies were below the limit of
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detection in the brain of HK483 infected ferrets at 4 dpi and significantly lower than those
measured from VN1203 infected ferrets at later time points (Figure 4B,D,F, ANOVA, p <
.01). Collectively, these data indicate that VN1203 replicated to a higher titer in the brains of
ferrets compared to HK483 at similar time points following infection and HK483 entry into
the brain was delayed and less severe compared with VN1203.
Localization of HPAI infection in the brain
Routes of infection in the CNS have been suggested (10-12, 21, 27); however, the
dissemination of virus in the brain remains unknown. To localize VN1203 and HK483

cerebellum were obtained from formalin-fixed, paraffin-embedded brain tissues and
examined by immunohistochemistry for avian influenza NP. Normal morphology was
observed in the frontal cortex of mock-infected ferrets (Figure 5A) and HK483 NP antigen
could not be detected from any brain section of ferrets challenged with HK483 and examined
4 dpi (Figure 5B and 5E). A single focus of staining was observed in the olfactory nucleus
of one ferret each at 6 and 8 dpi (data not shown). Strikingly, numerous distinct foci of
VN1203 NP expression were detected 3 dpi in the olfactory bulb and frontal cortex (Figure
5C) and similar expression was also observed 4 to 6 dpi. Foci were widespread and contained
numerous nuclear-stained cells (Figure 5F).
Similar to observations in the frontal cortex, multiple foci of VN1203 were identified
3 dpi in the occipital cortex of the temporal lobe, the ectorhinal cortex, striatum,
somatosensory area of the parietal lobe, the internal capsule, and the adjacent thalamus
(Figure 6A). In contrast, no viral antigen was detected in these regions of ferrets infected
with HK483 and examined at 4, 6, or 8 dpi (Figure 6B). Foci of VN1203 were numerous,
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widespread, and concentric in appearance. Furthermore, virus was also identified in the
dorsal cerebral cortex where no histologic alterations or inflammatory cell infiltration was
observed (Figure 6C). VN1203 was observed in the internal capsule (Figure 6D) and the
adjacent thalamus (Figure 6E), representing new areas of infection that have not been
described previously. Foci in these regions were similar to those in other brain regions.
Hindbrain tissue sections were obtained from infected ferrets and assessed for HK483
and VN1203 at multiple time points. Hindbrain regions included the cerebellum, pons,
medulla, and the most rostral aspects of the spinal cord (Figure 7A). Hind rains from
HK483-inected ferrets appeared normal with an absence of any immunohistochemical
staining for influenza NP at any time during the infection period and concurrent with active
infection in the respiratory tract (Figure 7C,D,I,J). In contrast, viral antigen was observed in
multiple regions of the brain stem, cerebellar peduncles, and cerebrobulbar tracts in white
and gray matter areas. More specifically, multiple foci of infection were identified in the
Purkinje cells of the cerebellar foci (Figure 7K,L) with occasional staining extending into
the granular layer, which is penetrated by Purkinje cell axons. Interestingly, the adjacent
molecular layer that consists of dendrites extending from the Purkinje cells exhibited a
complete lack of VN1203 staining, suggesting directional migration of VN1203 at least in
the cerebellar folia. The widespread dissemination of VN1203 suggests that the virus did not
spread from a single dissemination site.
Brain lesions during HPAI infection
Tissue sections from the forebrain, midbrain and hindbrain were randomly selected,
stained by hematoxylin and eosin and examined under light microscopy for evidence of
histological changes related to viral neuroinvasion. In contrast to ferrets infected with
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VN1203 in which brain lesions were present on 3 dpi, there were no histological alterations
in the brains of ferrets infected with HK483 examined on 4 dpi. Two of six HK483 infected
animals examined on 6 dpi had acute neutrophil inflammatory cell infiltration in the olfactory
system located in the olfactory nuclei in the frontal cortex (Figure 8B,E), the olfactory
cortex in the temporal lobe, limbic system, and the somatosensory area in the parietal lobe.
One of the two ferrets with observed inflammatory cell infiltration had viral antigen present
in the olfactory nuclei while it was not detected elsewhere in the brain (data not shown). Two
of six HK483 infected animals examined 8 dpi had more advanced mild to moderate acute
inflammation limited to the olfactory system. Likewise, immunostaining was observed in
only the olfactory nucleus in one HK483 infected ferret 8 dpi. Meningoencephalitis was
pronounced in the olfactory system in a HK483 infected ferret that had lost more than 25% of
its initial body weight, and had no neurological signs when examined 11 dpi.
Histological examination of ferrets infected with VN1203 on days 3-6 post challenge
showed widespread lesions in gray and white matter areas in the frontal cortex (Figure
8C,F), thalamus, parietal and temporal lobes, midbrain/medulla (Figure 8I,L), and hind
brain cerebellum folia (Figure 8O) in eight of ten animals, in sharp contrast to the brains of
ferrets infected with HK483 where lesions were not observed (Figure 8B,E,H,K,N). Figure
8A, D, G, J, and M demonstrate healthy mock infected brain sections of ferrets. Low
numbers of neutrophil infiltration in the olfactory bulb, and areas of cell death and/or loss of
cellularity were evident in all brain regions of VN1203 infected ferrets. Microglial nodules
were observed in regions near influenza foci (Figure 8C,F). Furthermore, inflammation of
the meninges was evident in the frontal cortex consisting of increased cellular infiltration and
increased size of the arachnoid space (Figure 8C). Lesions observed in the cerebrum and
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cerebellum of VN1203 infected ferrets corresponded to regions of viral antigen detection by
immunohistochemistry while HK483 infected ferrets did not have lesions or viral antigen
detected in the cerebrum or cerebellum.

Discussion
Although neuropathogenesis and neurological sequelae have been recognized for
HPAI infection, little is known about the contribution of neuroinvasion to lethality against
the well-studied role of respiratory disease during influenza infection. Here we show that
low infectious titers of distinct H5N1 HPAI viruses produce divergent disease outcomes
amid distinct neurovirulence. We also show that neurological signs are important indicators
of replicating virus in the brain and likely foretell morbidity and lethality in the ferret model.
Infection with the clade I prototypic strain VN1203 at low inoculating titers led to substantial
lethality and neurological signs, whereas the clade 0 prototypic strain, HK483, resulted in
less lethality and no neurological sequelae. While cells of the lower respiratory tract are often
the primary targets of influenza A virus, nasal turbinate cells including neuroepithelial
bundles of the olfactory tract are also permissive to infection. In primary differentiated ferret
nasal turbinate cells in culture, VN1203 and HK483 replicated to similar titers consistent
with data obtained from the nasal turbinates of VN1203 or HK483 infected ferrets. Likewise,
while the damage caused by each virus was distinct, the viral replication was similar in the
lungs of ferrets infected with either VN1203 or HK483 suggesting that productive infection
in the respiratory tract was an insufficient predictor of lethality in this model.
Remarkably, VN1203 infection was multifocal and widespread throughout the brain
while HK483 was much less neurotropic with lesions limited to the olfactory system. The
absence of neurological clinical signs in ferrets infected with HK483 correlated with
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histopathological immunostaining that demonstrated virus was limited to the olfactory
system. The restriction of virus primarily to the olfactory nucleus and olfactory cortex also
correlated with the low viral RNA copy number in the brain. Viral RNA was detected in the
olfactory bulb of approximately 75% of animals 6 and 8 dpi. All HK483 infected animals
were negative on 4 dpi showing a delayed time course of transmission of virus to the
olfactory bulb and brain in ferrets infected with HK483 compared to VN1203. These findings
suggest differences in pathogenesis and neurotropism that correlated with the extent of
dissemination within the CNS and are possibly indicative of differences in viral replication in
the CNS. The prominent histological damage in the central olfactory system in the brain at 6
and 8 dpi in ferrets infected with HK483 were associated with marked inflammatory cell
infiltration and showed HK483 induced alterations associated with only low levels of viral
RNA detected in the brain by qRT-PCR. Multiple brain regions (forebrain, midbrain, and
hindbrain) and several tissues within each region were found to have active VN1203
replication.
HK483 and A/Hong Kong/486/1997 have been used in murine models of infection to
identify routes of neuroinvasion, and from these studies, the trigeminal, vagus, and
sympathetic nerves (11, 12, 27) were identified in addition to the olfactory nerves. In the
present study, virus expression was detected in the trigeminal and facial nuclei in the
brainstem of ferrets infected with VN1203. Fibers from these nuclei are distributed in the
reticular activating system and enter the cerebellum through the cerebellar peduncles. They
also project to the thalamus and connect to the motor cortex via the corticobulbar tract.
Ferrets had clinical signs of ocular discharge indicative of conjunctivitis, a possible site of
entry into the terminal tributaries of the trigeminal nerve. The hypoglossal nerve innervates
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the tongue and pharynx and the nucleus in the brainstem receives efferents from the sensory
trigeminal nuclei. The data presented here indicate that the olfactory nerves may be an
important conduit of neuroinvasion; however, other routes are plausible based on our
findings of VN1203 replication and pathogenesis in multiple brain regions.
Other viruses such as JC virus, poliovirus, Epstein-Barr virus, mouse adenovirus 1,
human T-lymphotropic virus type 1, and West Nile virus are known to infect the CNS
through the vascular endothelium (28). HPAI has not been shown to enter the CNS through
this route and virus was not detected in the CNS endothelium of the ferrets infected with
VN1203 or HK483 in this study. A more likely method of CNS entry is through the
peripheral nerves. It has been shown that poliovirus, adenoviruses, and rabies bind to neurons
at the neuromuscular junction where specific receptors are expressed (28). While influenza
receptors on neurons are not known, Jang et al (29) used microfluidic chambers to show
VN1203 could be transported from the processes of freshly dissociated dorsal root ganglia
cells of mice to the cell body in a separate compartment. This finding demonstrated that
VN1203 traveled via the axons suggesting a method for transport of H5N1 to the CNS. Here,
the distribution of virus antigen throughout various regions of the brain indicates that
VN1203 may have entered the brain via multiple cranial nerves though the mechanism
remains to be elucidated.
The infection of the olfactory region may be particularly important in the widespread
infection observed in multiple brain regions prior to death. Cell death and ulceration of
sensory epithelial cells with clinical signs of nasal discharge and viral expression strongly
suggest that the nasal infection was the route of entry into the olfactory bulb and for
subsequent dissemination in the central olfactory nervous system of both stains of virus.
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Influenza has been shown to infect olfactory nerves (18, 19, 27) and immunostaining
demonstrated virus expression in areas in the cerebrum in which mitral cells project from the
olfactory bulb to synapse in the anterior olfactory nucleus, the olfactory cortex in the
temporal lobe, the amygdala, the piriform cortex, and the entorhinal cortex. Multiple
projections from the olfactory bulb may explain some of the widespread viral antigen
observed in the cerebral cortex. The olfactory system is the only cranial sensory system that
has direct projections into the cerebral cortex without relay in a thalamic nucleus. Also, the
close neuroanatomical connections of the olfactory system to the limbic system help explain
VN1203 distribution in the hippocampus and the striatum.
The nature of the neurological signs following VN1203 infection may have important
implications for clinical evaluation of active H5N1 infection. Animals that succumbed to
VN1203 infection at 3 dpi exhibited convulsions leading up to death. Consistent with these
findings, VN1203 was isolated from the cerebral cortex from all animals that exhibited these
signs. Further evidence of the link between viral localization and specific neurological signs
can be observed in the later phase of lethality to VN1203. Ferrets that succumbed to infection
at 5 or 6 dpi exhibited a lack of voluntary movement control and coordination. Upon analysis
of viral localization in the brain, virus was isolated from the deep cerebellar nuclei, an area
known to be important in motor control and gait. One important finding from the current
studies is the elucidation of Purkinje cells of the cerebellar foci as a strongly permissive cell
for H5N1 infection. Likewise, the granular layer, a region that receives axons from the
Purkinje cells, but not the molecular layer, which consists of dendrites from Purkinje cells,
was found to have substantial viral antigen staining and may indicate directional migration of
H5N1 in neuronal tissues. Although further study is warranted, the notion that specific
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neurological signs may be used to ascertain the presence of virus in various brain regions
may become useful should therapeutics targeting neurological infection become available.
The neurovirulence and mechanisms of brain pathogenesis of HPAI H5N1 are not
known and require further study. Clearly, viral determinants exist in different H5N1 viruses
that lead to neurotropism in ferrets. Further studies to ascertain the mechanism by which
H5N1 enters into and is disseminated throughout the brain will be important for identifying
H5N1 viruses through global surveillance that may have enhanced pathogenesis in humans.
Additionally, the route of infection and dissemination within the brain should be more clearly
defined to provide clinicians with more markers of brain involvement in H5N1 infection and
to identify novel areas as targets for therapeutics to prevent virus dissemination to the CNS.
It is also unclear whether entry routes along different cranial nerves require specific receptors
for viral entry, or if it is opportunistic in nature. Furthermore, therapeutic approaches that
target influenza in the brain will likely need investigation in light of the rapid onset of
neurological signs in human cases. While not widely appreciated outside of the influenza
research community, the importance of neurological disease in HPAI should be emphasized
in future public health initiatives.
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Figure Legends
Figure 1. VN1203 was more lethal than HK483 in ferrets despite similar weight loss
in non-survivors. A. Survival of ferrets intranasally challenged with allantoic fluid (N =
2), A/Vietnam/1203/2004 (VN1203) (N = 10) or A/Hong Kong/483/1997 (HK483) N =
10, ***, p < .0001. B. Mean + SEM of bodyweight of ferrets instilled with VN1203 or
HK483. N = 8 HK483 survivors, N = 2 HK483 non-survivors, N =10 VN1203 nonsurvivors, N = 2 control.
Figure 2. VN1203 induced significant pathology despite similar nasal turbinate
titers in ferrets infected with either virus. A. H&E stained section a primary
differentiated ferret nasal turbinate cell monolayer. B. Primary differentiated ferret nasal
turbinate cells were infected with VN1203 or HK483 at an MOI of 0.001. Mean + SEM
of N = 4 samples per virus at each time point. C. Viral titers of homogenized nasal
turbinates were graphed as mean + SEM for VN1203 or HK483 infected ferrets. D-I.
Representative samples of nasal turbinate tissue of ferrets instilled with allantoic fluid
(D,G), HK483 (E,H), or VN1203 (F,I). D-F were stained with H&E, G-I were stained
with anti-avian influenza NP and counterstained with Luxol fast blue. F. # indicates
inflammatory cells infiltrating the underlying stroma. H,I. Arrows point to H5N1 infected
cells. Scale bars: A, 50m; D-F, 300m; G-I, 100m.
Figure 3. Viral titers and histopathology were similar in the lung of H5N1 infected
ferrets. A. Viral titers and B. viral RNA was measured from four sections of the lung per
ferret. A,B) Data represents the mean + SEM from four lung regions of N = 1, VN1203 4
dpi, N = 3, VN1203 6 dpi, N = 6, HK483 4, 6, and 8 dpi. Dorsal view of ferret lung
following intranasal instillation with allantoic fluid (C), HK483 (D), VN1203 (E). Lung
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sections stained with H&E of ferrets instilled with allantoic fluid (F), HK483 (G),
VN1203 (H). F-H) scale bars = 600 µm.
Figure 4. High viral titers were measured in the brain of VN1203 infected ferrets.
A,C,E) Viral titers were measured in three sections of the ferret brain. Titers were
graphed as mean + SEM for VN1203 or HK483 infected ferret olfactory bulb (A),
cerebral cortex (C), brain stem (E). Viral RNA was extracted from homogenized tissue
and graphed as the mean + SEM of viral RNA copies per gram of tissue from VN1203 or
HK483 infected ferrets' olfactory bulb (B), cerebral cortex (D), brain stem (F). White
bars: HK483 infected ferrets, black bars: VN1203 infected ferrets. All mock infected
ferrets were negative for virus. n.d. indicates virus or viral RNA was not detected.
VN1203: N = 4, 3 dpi; N = 1, 4 dpi; N = 2, 5 dpi; N = 3, 6 dpi. HK483: N = 6; 4, 6 and 8
dpi.
Figure 5. VN1203 infection in the ferret brain was multifocal and evident in the
olfactory tract.
Representative sections from the frontal lobe of ferrets intranasally instilled with allantoic
fluid (A,D), on: olfactory nucleus, rf: rhinal fissure, HK483 (B,E) or VN1203 (C,F) were
stained for viral antigen with IMGENEX 5187-A for avian influenza A NP and
visualized with DAB. Brown stain indicates the presence of virus. Counterstained with
Luxol fast blue. Scale bars: A-C) 5mm, D-F) 300µm.
Figure 6. VN1203 infection resulted in multifocal infection in the cerebral cortex of
ferrets.
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Representative sections of the cerebrum of ferrets intranasally instilled with VN1203 (A,
C-E) and HK483 (B). Viral antigen was detected with IMGENEX-5187A for avian
influenza A NP and visualized with DAB. Brown stain indicates the presence of virus.
Counterstained with Luxol fast blue. Scale bars represent 10 mm. cc: corpus collosum, ic:
internal capsule, ot: optical tract, h: hippocampus, lv: lateral ventricle, oc: olfactory
cortex, cp: cerebral peduncle.
Figure 7. VN1203 infected and replicated in Purkinje cells and deep cerebellar
nuclei of the cerebellum.
Representative sections of the cerebellum of ferrets instilled with allantoic fluid
(A,B,G,H), HK483 (C,D,I,J), VN1203 (E,F,K,L). Viral antigen was detected with
IMGENEX 5187-A for avian influenza A NP and visualized with DAB. Brown stain
indicates the presence of virus. Counterstained with Luxol fast blue. (B-F) higher
magnification of boxes in A-E respectively. H) White arrow indicates molecular layer,
black arrow indicates granule layer, black arrowhead indicates a Purkinje cell, white
arrowhead indicates Purkinje cell axons. L) Arrow indicates infected granule cell and
arrowhead indicates infected Purkinje cell. Scale bars represent: A,C,E,G,I,K) 2mm;
B,D,F,H,J,L) 300 µm.
Figure 8. VN1203 resulted in severe and widespread brain lesions compared with
HK483.
Representative sections from the olfactory nucleus (A-F), cerebrum (G-L), and
cerebellum (M-O) were taken from ferrets instilled with allantoic fluid (A,D,G,J,M),
HK483 (B,E,H,K,N), VN1203 (C,F,I,L,O) and stained with H&E for evaluation of
histological alterations. B) Arrow points to meningeal inflammatory cell infiltration,

65

asterisk denotes infiltration of neutrophils. D-F) High magnification of boxes in A-C
respectively. O) Asterisk denotes lesion. Scale bars: A-C, J-L, M-O) 1mm, D-F) 300µm,
G-I) 5 mm.
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Table
Table 1. Clinical observations in ferrets post-challenge with VN1203 or HK483.
Number of ferrets with clinical symptoms

H5N1 strain
VN1203
HK483

(# with symptoms/total # in group)
Nasal
Ocular
Neurological
Discharge
Discharge
Symptoms
8/10
10/10
2/10
10/10

0/10

4/10
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Abstract
The aerobiology of influenza infection, including the highly pathogenic avian influenza
(HPAI) H5N1 virus remains elusive. An increased understanding of the pathogenesis of
infection by airborne influenza is critical to the understanding of human influenza
disease. Herein, we elucidate unique sequelae of aerosolized influenza in an experimental
model of infection. Following aerosol infection, viral antigen was widely disseminated
throughout the central nervous system concomitant with lesions in the olfactory bulb,
frontal lobe, cerebral cortex, thalamus, and brain stem. Lesions were commonly found in
areas that could explain the neurological signs observed especially in the brain stem. This
model more closely resembles natural human infection by exposing subjects to small
particles of aerosolized influenza, which is how humans are generally exposed to the
virus. Furthermore, the results of this study highlight that aerosolized HPAI can result in
neuroinflammation and cause lesions in the brain and that neuropathogenesis is not a
consequence of intranasal instillation. Such lesions could induce neurological signs that
may be used by clinicians in the diagnosis of patients that present with atypical symptoms
following HPAI exposure.
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Introduction
Highly pathogenic avian influenza (HPAI) continues to infect humans with a high
mortality rate. Since 2003, the World Health Organization has reported 608 confirmed
human cases of HPAI subtype H5N1 and 359 deaths
(http://www.who.int/influenza/human_animal_interface/EN_GIP_20121217CumulativeN
umberH5N1cases.pdf, accessed 15January2013). The high mortality rate of this emerging
virus emphasizes the need to study the pathogenesis of H5N1 infection to identify new
targets for vaccines and therapeutics, increase the awareness of neurological signs and
possible sequelae caused by HPAI infection, and aid clinicians in quickly diagnosing
infection when patients present with non-respiratory symptoms.
Different routes of influenza exposure have recently been studied to identify
differences in morbidity and lethality although more work needs to be done to
characterize differences in pathogenesis of H5N1 infection following different routes of
exposure to the virus (1). Ferrets are commonly used as a model for H5N1 infection and
while intranasal instillation is often used as the means for infecting ferrets, studies have
shown that aerosol exposure more closely represents the method by which humans
typically become infected with airborne influenza virus (2-4). However, little is known
regarding the neuropathogenesis of aerosolized H5N1 in mammals.
Neurotropism is a key feature of avian influenza in naturally susceptible
populations of avian species (5, 6). Understanding the mechanism of how virus enters
into the brain and disseminates so quickly is important for identifying outbreaks before
entire flocks are destroyed and before humans become infected with newly emerging
strains. Importantly, neurotropism has been recognized in several mammalian species
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such as domestic cats, tigers and leopards, mice, and others (5-7). While limited autopsy
information is available on fatal HPAI infection in humans, H5N1 has been detected in
the brain and cerebrospinal fluid of some patients following clinical presentation of
diarrhea, generalized convulsions, seizures, and ultimately coma (8-14). Neurological
signs are not specific to H5N1 as a study of twelve major influenza pandemics in humans
throughout the 20th and 21st centuries noted delirium, encephalitis, ocular abnormalities,
amyotrophy, myelopathy, radiculopathy, ataxia, and seizures were reported as
neurological manifestations of influenza infection (15).
In this study, we have developed a nose-only aerosol model that exposes naïve
ferrets to H5N1 to represent the method by which mammals are naturally infected with
influenza virus and to examine the neuropathogenesis of the virus at the time of death. It
has been suggested that the neurotropism of H5N1 observed in experimentally infected
animals is a result of intranasal instillation. In this paper, we show that exposure via
aerosolized H5N1 leads to widespread multifocal infection throughout the brain with
significant pathology concomitant with detectable infection and consistent with recorded
neurological signs of infection.

Materials and Methods
Ethics statement
All animal procedures were conducted with the approval of the Institutional
Animal Care and Use Committee (IACUC) and institutional biosafety committee of the
Lovelace Respiratory Research Institute (LRRI), Albuquerque, NM. LRRI’s animal
facilities are accredited by the Association for Assessment and Accreditation of
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Laboratory Animal Care International. Ferret experiments were conducted in the Animal
Biosafety Level 3 (ABSL-3) enhanced facility.
Virus preparation
The highly pathogenic avian influenza A (HPAI) H5N1 virus,
A/Vietnam/1203/2004 (VN1203) was isolated from a patient with a fatal case of
influenza in 2004 and was obtained from the Centers for Disease Control and Prevention
(Atlanta, GA). The virus was passaged once from the CDC stock in eggs, aliquoted,
titrated by plaque assay on Madin-Darby Canine Kidney (MDCK) cells, and stored at 80C. All manipulations with this virus strain were conducted under Biosafety Level 3
(BSL-3) conditions in the BSL-3 enhanced or animal BSL-3 enhanced (ABSL-3) facility
at the Lovelace Respiratory Research Institute in Albuquerque, New Mexico.
Ferret handling/care and infection
Castrated male ferrets (Mustela putorius furo), approximately nine months of age,
weighing ~1 kg, (supplied by Triple F Farms, Sayre, PA) were pre-screened by the
supplier for H1 and H3 influenza A and influenza B seroconversion prior to shipment.
Ferrets were triple-housed throughout quarantine (14 days) but single housed in stainless
steel cages after virus challenge. Ferrets had access to food and water ad libitum.
Temperature and humidity ranged 16 to 22C and 30 to 65%, respectively and the light
cycle was 12 hr on and 12 hr off. Ventilation in the study room was >15 air exchanges
per hr. All ferret handlers had been vaccinated for circulating seasonal influenza strains
and were not permitted to enter ferret quarters if they exhibited any symptoms of upper or
lower respiratory infection.
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Ferrets were anesthetized with an intramuscular injection of a ketamine/xylazine
mixture (20mg/kg of ketamine and 4 mg/kg of xylazine) prior to implantation of two
IPTT-300 Implantable Programmable Temperature and Identification Transponders (Bio
Medic Data Systems, Inc, (BMDS) Seaford, Delaware). One microchip was implanted
between the shoulders and one was implanted in a rear leg and both provided
subcutaneous body temperature data throughout the study using a BMDS electronic
proximity reader wand (WRS-6007; BMDS).
Viral infection procedures
Ferrets (n = 6) per group were challenged with the A/Vietnam/1203/2004 strain
of H5N1 by nose only inhalation. Aerosols were generated with a Collison compressed
air jet nebulizer (BIG Incorporated, Waltham, MA) from a suspension of virus in serum
free media. Aerosols were characterized for viral concentration by collection into an all
glass impinger (AGI). The AGI was filled (20 mL) with serum-free minimal essential
medium (MEM) (Gibco # 42360-032) supplemented with 1X anti-mycotic, anti-biotic
(Gibco # 15240) plus 8 drops of antifoam agent B. Particle size of the aerosol was
measured with the GRIMM aerosol spectrometer (GRIMM Aerosol Technik GmbH &
Co.). Particle size data were reduced to calculate the mass median aerodynamic diameter
(MMAD, in µm) and geometric standard deviation (GSD).
Presented dose of the virus was determined by estimation of respiratory minute
volume (16), measured aerosol concentration, and actual exposure time (17). All doses
are reported as presented dose and therefore utilize a deposition fraction of 1.
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Clinical observations
Clinical observations were conducted twice daily and included recording clinical
signs of disease, body weights, and the monitoring of body temperature changes twice a
day in response to infection via implanted BMDS microchips as described above. Study
personnel were trained specifically in ferret handling procedures and the observation and
recording of adverse signs and clinical symptoms in ferrets. Observations were recorded
using the electronic Provantis system. The onset, nature, severity, and duration of all
visible changes such as abnormal respiration, dehydration, emaciation, excretory,
behavioral, and neurological signs (i.e., paresis, torticollis, loss of righting or startle, head
tilt, and paralysis) were recorded as well as any observed coughing, sneezing, and nasal
or ocular discharge. Additionally, an activity score was assigned at each observation as
follows: (0 = alert and playful, 1 = alert but playful only when stimulated, 2 = alert but
not playful when stimulated, and 3 = neither alert nor playful when stimulated).
Moribund criteria were established in the approved IACUC protocol as body
weight loss of more than 25% of their day 0 body weight, a decrease in body temperature
to less than 92°F, indicative of shock, unresponsiveness to touch, self-mutilation,
convulsions, paralysis or any movement disorder, or respiratory distress.
Histology and immunohistochemistry
Lungs (pressure fixed with 25 cm of hydrostatic pressure) and whole brain were
fixed in 10% neutral buffered formalin for at least seven days and then changed to 70%
ethanol. Representative samples of fixed tissues were trimmed, processed routinely, and
embedded in paraffin. Tissue sections (4-6 µm) were cut and stained by H&E for
histopathology examination. Immunohistochemical staining was conducted using

82

described protocols (18). Briefly, paraffin-embedded tissue sections were deparaffinized
in xylene and decreasing concentrations of ethanol. Antigen retrieval was completed with
a citrate buffer and endogenous peroxides were blocked with hydrogen peroxide in
methanol. Slides were then incubated with 10% blocking buffer with goat serum, and the
primary antibody (IMG-5187A, IMGENEX, San Diego, CA) was applied at a dilution of
1:800 overnight, 4ºC. An anti-rabbit biotinylated secondary antibody (Vector
Laboratories Inc., Burlingame, CA) was then applied at a dilution of 1:250 for one hour
at room temperature. The ABC standard kit by Vectastain (Vector Laboratories Inc.,
Burlingame, CA) was used in conjunction with a DAB kit (Vector Laboratories Inc.,
Burlingame, CA) to detect antibody. Stained sections were then counterstained with
hematoxylin, acid alcohol, and ammonium hydroxide, and rehydrated in increasing
gradients of ethanol and xylene, and coverslipped. Images were acquired using the
Hamamatsu 2.0 NanoZoomer software (Hamamatsu Corp., Bridgewater, NJ).
Characterizations of histopathologic lesions were made with the assistance of a boardcertified veterinary pathologist unfamiliar with the study design. Anatomic lesion
distribution determinations were made by JRP with pathology consultation.
Statistical Analysis
GraphPad Prism 5, software version 5.04 (La Jolla, CA) was used to graph data
and perform statistical analysis. The Kaplan Meier procedure was used for the survival
analysis and an analysis of variance (ANOVA) was used for comparing multiple means.
Mean + SEM is graphed and p < .05 was considered statistically significant.
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Results
Survival and clinical signs of H5N1 infection in ferrets using aerosol delivery
Experimental studies of H5N1 infection in ferrets almost exclusively use
intranasal instillation as the method for infection. However, natural exposure to influenza
occurs via the presence of virus in aerosols that are inhaled and deposited in the upper
respiratory tract. In this study, three groups (six ferrets per group) were exposed to
varying quantities of aerosolized A/Vietnam/1203/2004 (VN1203), a highly pathogenic
avian influenza (HPAI) strain shown to have high lethality in ferrets following intranasal
instillation (19-21). Aerosolized VN1203 was presented to ferrets in nose-only exposure
chambers to ensure the efficient delivery of the targeted amount of virus to the upper
respiratory tract. The particle size of the viral aerosols were all ~2.1m MMAD with
GSD’s of ~1.3, which are highly respirable for ferrets. Concentrations of 0 to 2,561
plaque-forming units (PFU) per mL were utilized in the nebulizer, which resulted in
presented doses of between 0 and 32 PFU.
Ferrets were humanely euthanized after meeting moribund criteria of the study as
described in the methods between 4 and 8 days post-exposure (dpe). There was 100%
lethality in the group of ferrets receiving the high dose of VN1203 (32 PFU) and the
group exposed to the low dose of 0.2 PFU had 67% lethality (Figure 1A).
The median survival for both groups was 6.5 days. All six of the ferrets presented
with the highest dose of 32 PFU developed neurological signs such as paralysis, loss of
startle, twitching, head tilt, loss of righting, and torticollis between 5 and 8 dpe. One
ferret in the group receiving 0.2 PFU was observed to be afflicted with paresis and
torticollis at 8 dpe (Table 1).
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Body temperature was obtained throughout the study from microchips implanted
in the shoulder and leg of ferrets. Non-surviving ferrets developed a fever of two degrees
elevated from their initial body temperature pre-exposure (Figure 1B). Similar to results
in our laboratory following intranasal instillation at various doses, weight loss was not
significantly different between groups suggesting weight loss was not dose dependent
following aerosol infection of VN1203 (Figure 1C).
Aerosol exposure to VN1203 results in severe histopathology in the lung
Ferrets exposed to VN1203 via nose-only aerosol developed severe respiratory
disease in the lung. Histological examination of lung sections showed widespread
inflammation throughout the lung regardless of the amount of virus to which ferrets were
exposed. In the most severely affected lungs, marked, widespread inflammatory
infiltrates with edema and fibrin resulting in a loss of normal alveolar structure over large
areas was observed. Intrapulmonary bronchioles were often obstructed by cellular debris
and proteinaceous material (Figure 2A and B). In the mild to moderately diseased lungs,
there was multifocal inflammation and the epithelial lining of the airways was disrupted
(Figure 2C). Cells infected with VN1203 were identified through immunohistochemical
staining with an antibody to avian influenza nucleoprotein and could be found throughout
the damaged lung (Figure 2D and E). Cells positive for viral antigen were not
commonly found along the damaged airway due to the loss of epithelial cells lining the
airway.
H5N1 infection in the olfactory bulbs and frontal lobe of the ferret brain following
aerosol exposure
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H5N1 has been shown to cause neurological signs at low doses following
intranasal instillation (19) and following nose-only aerosol delivery at higher doses (2, 3).
However, the distribution of H5N1 in the brain following low dose aerosol delivery has
not been studied. In this study, exposure to the lowest dose delivered resulted in virus
distributed widely throughout the brain of ferrets. Viral antigen was consistently detected
in the olfactory bulbs of ferrets at the time of death following exposure to the low or high
dose (Figure 3F-H). Specifically, in the olfactory bulbs of infected ferrets, virus was
detected in many of the cells surrounding the glomeruli in the glomerular layer (Figure
3F and G). The mitral cell layer and the granule cell layer also contained cells positive
for H5N1; however the virus appeared to be more diffuse in these areas compared with
the glomerular layer where staining intensity tended to be greater in the nuclei (Figure
3H).
Examination of the olfactory bulbs showed hemorrhage occurred in 40% of
ferrets exposed to the low dose and 33% of those exposed to the high dose. When they
occurred, hemorrhages were often observed in the external plexiform layer just deep to
the glomerular layer, in the granule cell layer (Figure 3B and C), and in the accessory
olfactory bulb. Lymphocytic inflammation in the glomerular layer with perivascular
cuffing (meningoencephalitis) was also observed in the olfactory bulb of all ferrets
examined (N = 6, high dose; N = 5, low dose).
VN1203 was widely distributed throughout the frontal lobe of ferrets exposed to
the low or high dose of H5N1 as determined by immunohistochemical analysis. The viral
distribution was multifocal with viral antigen found particularly in the grey matter and
neuropil surrounding blood vessels although viral antigen was not detected within
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endothelial cells or cells of the vascular tunics. Unlike the distinct circular areas of
infected cells observed following intranasal instillation at low doses of VN1203 (19),
virus was more widespread and diffuse following aerosol exposure with larger areas of
infection detected (Figure 4A and D). On average, approximately 17% of the total
frontal lobe section examined for each ferret was positive for influenza infection in
ferrets exposed to either the low or high dose of H5N1 with as much as 34% of the
frontal lobe containing positive cells in one ferret from the low dose group.
Meningoencephalitis, inflammation of the meninges concurrent with
inflammation in the brain, was also observed in all ferrets examined with perivascular
cuffing and lymphohistiocytic inflammation observed extending into the gray matter of
the frontal lobe (Figure 4B). Karyorrhexis (fragmented nuclear debris) was commonly
observed in areas with detectable virus in all animals and hemorrhage was observed in
one ferret that was exposed to the higher dose of VN1203 (Figure 4B, C, E).
H5N1 was widely distributed throughout the cerebral cortex and hippocampus of
ferrets following aerosol exposure
Ferrets exposed to VN1203 via aerosol also had moderate to severe inflammation
in the meninges surrounding the cerebrum (Figure 5A). Similar to what was observed
around the frontal lobe, perivascular cuffing and lymphocytic inflammation was also
apparent in the cerebral cortex (Figure 5B). Karyorrhexis was consistently found in areas
positive for viral antigen (Figure 5B, C, E, and F) and nuclear fragmentation and viral
antigen were observed in the hippocampus (Figure 5G-J). Karyorrhexis was also found
in the piriform lobe in conjunction with the detection of viral antigen.
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In some ferrets, foci of VN1203 infection in the neocortex were discrete with
distinct edges to the infected areas, similar to foci observed following intranasal infection
with VN1203 at low doses. However, many ferrets exposed to low doses of VN1203 via
aerosol exhibited viral distribution that was diffuse with virus found throughout the grey
matter of the neocortex (Figure 5D).
Virus was widespread in the diencephalon of ferrets exposed to VN1203 via aerosol
Ferrets exposed to VN1203 via aerosol exhibited widespread multifocal infection
throughout the thalamus, particularly in thalamic nuclei and infected areas ranged from
multi-focal to diffuse regardless of exposure to the low or high dose (Figure 6A and B).
Approximately 20 foci of viral antigen were detected in the thalamus per animal
examined with infection detected throughout 34% of the thalamus. In contrast to viral
antigen detection by immunohistochemical analysis, pathology observations were
different between groups when H&E stained sections were examined. Exposure to the
lower dose of VN1203 consistently resulted in distinct foci of karyorrhexis in the
thalamic nuclei and in the tissue surrounding blood vessels in the thalamus. Mild to no
inflammation was observed (Figure 6C and D) in conjunction with viral antigen
detection. Lymphocytes and macrophages were marginated within the blood vessels of
some ferrets exposed to the lower dose and hemorrhage was observed in one animal at
the low dose.
Cell death was more widespread in the thalamus of ferrets exposed to the higher
dose of VN1203 with moderate inflammation observed (Figure 6E and F). Discrete
edges to the karyorrhectic areas often could not be identified in these ferrets with larger
areas exhibiting widespread cell death than seen in low dose animals. Perivascular
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cuffing was observed with lymphocytic inflammation extending from the vessels into the
thalamus with lymphocytes and histiocytes often visible within the vessels. Hemorrhage
was observed in one ferret exposed to the higher dose and it was more severe than the
single instance of hemorrhage observed in the group exposed to the low dose of VN1203.
The habenular nuclei, located in the epithalamus, were positive for viral antigen
with substantial cell death also observed. Interestingly, the endothelial and other vascular
cells were negative by immunohistochemical staining while the cells within neuropil
surrounding the vessels were positive (Figure 6G and H).
Immunopathology of VN1203 infection in the cerebellum and brain stem of ferrets
following aerosol exposure
Virus was detected by immunohistochemical analysis in the Purkinje cells of the
cerebellum in both groups of ferrets (Figure 7D). Rare foci of cellular debris were
observed in areas of infected Purkinje cells (Figure 7A) and inflammation was not
observed in any layer of the cerebellar cortex. Virus was also detected in the fastigial and
interpositus nuclei of the cerebellum (Figure 7E and F) and significant cell death was
observed in these areas by examination of H&E stained sections (Figure 7B and C).
H&E stained tissue sections that contained the brain stem at the levels of the
cerebrum and cerebellum were examined and histological observations were recorded.
Fifty percent of sections examined from the low dose group exhibited significant areas of
cell death with karyorrhexis commonly observed (Figure 8A). The areas of cellular
debris observed in the brain stem of ferrets exposed to the lower dose of VN1203 were
much smaller than those observed in the high dose group. The foci of debris were discrete
and widespread throughout the brain stem. In the group that received the high dose of
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VN1203, 80% of sections examined contained areas of karyorrhexis that were
widespread with discrete edges not well defined (Figure 8B and C). Most fields of
cellular debris were large with foci infringing on each other to form large areas of
damaged tissue. Perivascular cuffing was observed in 62% of brain stems examined from
the group that received the low dose (Figure 8A) and in 80% from the group that
received the high dose of VN1203 (Figure 8D). Infiltration of inflammatory cells was
also more frequently observed in the brain stem of ferrets that received the high dose of
VN1203 than those that received the low dose (Figure 8D). Significant hemorrhaging
was observed in one ferret that received the high dose.
Viral antigen was consistently detected by immunohistochemistry in the same
area as karyorrhexis and inflammation; however, it was not found in the ependymal cells,
endothelial cells, or within the lumen of the blood vessels (Figure 8E-H).. An average of
12 distinct foci including at least ten influenza infected cells per ferret were detected in
the brain stem following exposure to either the low or high dose of H5N1. Approximately
11% of the area examined in the brain stem of low dose animals and approximately 6%
of the area examined in the high dose group contained measurable foci of infected cells.
Discussion
Highly pathogenic avian influenza (HPAI) is commonly delivered intranasally to
experimentally infected ferrets in order to efficiently deposit the desired quantity of virus
to the upper respiratory tract. Other methods of HPAI instillation in ferrets have also been
examined to determine effects of the chosen delivery method and to identify the route
that results in pathogenesis most closely resembling what is observed in human cases of
HPAI infection (2, 3).
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In this study, aerosol exposure was used to study the pathogenesis of a more
natural route of infection in ferrets. Nose-only chambers were used to reduce the amount
of HPAI virus lost in large chambers or deposited on the ferrets’ fur. Clinical signs of
infection observed during the study period, morbidity, and analysis of histopathology
confirm aerosolized HPAI was highly lethal and caused severe disease in the lungs and
central nervous system. Compared to low doses of intranasally instilled VN1203, aerosol
delivery resulted in a more widespread distribution of virus throughout the brain and
substantially more inflammation than commonly observed in this laboratory following
intranasal instillation of low doses of VN1203 (19).
The virus initially infects the nasal epithelium where it rapidly replicates and is
likely disseminated to the CNS via nerves. The neuroepithelium of the nasal turbinates
include olfactory nerve fascicles in the olfactory mucosa that extend through the
cribriform plate to the main olfactory bulb (OB). The axons of olfactory receptor nerves
and their glia pass through the olfactory nerve layer and synapse on the dendrites of
mitral cells and tufted cells within the glomeruli of the olfactory bulbs. Both the mitral
cell layer and glomeruli were consistently infected with HPAI at the time of death and
significant pathology was observed in these areas.
From the main OBs, secondary projections extend directly to several regions
within the basal telencephalon that comprise the olfactory cortex. The mitral cells of the
OBs also project through the olfactory tract and lateral olfactory stria to the ipsilateral
olfactory cortex over the piriform lobe, which also contained detectable virus and
inflammation in this study. This suggests virus could pass directly from the OB to the
piriform lobe via the axons by using inherent mechanisms of the cells (e.g., anterograde
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or retrograde transport. It is important to note these connections do not pass through
thalamic nuclei.
Interestingly the thalamic nuclei were infected with HPAI and they receive axons
only from other diencephalic and telencephalic sources and not from the olfactory tract.
This suggests a route of CNS infection other than solely the olfactory tract. Some sources
of input into the thalamic nuclei are primary relay thalamic nuclei, thalamic reticular
system nuclei, the cingulate gyrus, and the frontal cortex, all of which were highly
infected with HPAI.
Viral antigen and cell death were also observed in the fastigial nucleus of the
cerebellum. This receives input from Purkinje cells and sends axons through the caudal
cerebellar peduncle to the reticular formation and vestibular nuclei to regulate muscle
tone and maintain balance. Each of these areas was also infected, which is consistent with
virus utilizing axonal transport mechanisms of neuronal cells to disseminate throughout
the CNS.
Many viruses have been shown to use axonal transport to impair neurological
processes and induce severe pathologies (22). Rabies can induce neurodegeneration (23),
Theiler’s murine encephalomyelitis virus causes demyelination (24) and Borna disease
virus can induce defects in synaptogenesis (25). Influenza infection has also been linked
to Parkinson’s disease due to inflammation caused by the infection (26). The connections
between regions of the ferret brain that contain significant amounts of detectable viral
antigen suggest that HPAI could be using the same mechanisms and routes as proteins
that are continuously trafficking throughout the CNS.
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Half of ferrets exposed to the low dose and all of those exposed to the high dose
of aerosolized H5N1 exhibited neurological signs such as head tilt, shaking of limbs, loss
of righting, loss of startle (which could indicate hearing loss), paralysis, torticollis, and
twitching. Some ferrets appeared unsteady on their feet as if they were experiencing
weakness (perhaps as a result of infection in the reticular formation of the brainstem).
The head tilt observed in four of the six ferrets exposed to the higher dose of aerosolized
H5N1 could be explained by the viral antigen and necrosis consistently found in the
vestibular nuclei. Specifically, lesions in the vestibular division of the cranial nerve (CN)
VIII typically manifest as head tilt toward the side of the lesion in affected animals.
Furthermore, the “loss of startle” combined with the head tilt observed in fifty percent of
ferrets exposed to the higher dose of H5N1 could be explained by damage to the
vestibular and cochlear nerves.
Understanding the correlation between the localization of virus, lesions, and
neurological signs observed during HPAI infections will help lead clinicians to more
rapid diagnoses and treatment of patients who do not present with typical respiratory
symptoms. Furthermore, elucidating the route HPAI takes to enter the CNS following
aerosol exposure could provide insight into viral characteristics that could be exploited in
the development of new vaccines, prophylactics, and therapeutics. Specific receptors or
pathways could be temporarily inhibited to stop the virus from entering the CNS where it
can induce severe disease, result in long-term illness, or result in death.
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Figure Legends
Figure 1. Survival, temperature, and bodyweight of ferrets following aerosolized
H5N1 exposure.
A: Survival of ferrets exposed to 0 (dotted line), 0.2 (dashed line), or 31.88 (solid line)
PFU of aerosolized A/Vietnam/1203/2004 (VN1203). B: Mean + SEM of temperature
from the shoulder microchip; C: Mean + SEM of body weight change; B, C: Ferrets
exposed to 0 PFU (open circles), 0.2 PFU (gray squares), or 31.88 PFU (black squares).
A-C: N = 6 per group.
Figure 2. Ferrets suffer from severely damaged lungs following aerosol exposure to
H5N1.
A-C: 5μm sections of inflation fixed, paraffin-embedded lungs stained with H&E. B:
Higher magnification of box in panel A. D-F: Viral antigen was detected with
IMGENEX-5187A for avian influenza A NP and visualized with DAB. Brown stain
indicates the presence of virus. E: Higher magnification of box in panel D. E,F: Arrows
points to cells positive for viral antigen.
Figure 3. Pathological findings and H5N1 nucleoprotein are detected in the olfactory
bulb of ferrets following aerosol exposure at a low dose.
A-D: 5μm sections of formalin fixed olfactory bulbs stained with H&E. A,E: Mock
infected. B-D, F-H: Aerosol exposure to 0.2 PFU of VN1203. C,G: Higher
magnification of box in panel B and F, respectively. Asterisk indicated glomeruli of the
glomerular layer. D: MCL: mitral cell layer, GCL: granule cell layer.
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Figure 4. Widespread distribution of H5N1and inflammation in the frontal lobe
following aerosol exposure in ferrets.
A,B: Viral antigen in the frontal lobe was detected with IMGENEX-5187A for avian
influenza A NP and visualized with DAB. Brown stain indicates the presence of virus. B:
Higher magnification of box in panel A. C: H&E stained section of the frontal lobe. Inset
is higher magnification of box.
Figure 5. Aerosol exposure to H5N1results in perivascular cuffing, karyorrhexis,
and widespread viral infection in the neocortex and hippocampus.
A-C: H&E stained sections of the cerebral cortex. D-F: Viral antigen in the cingulate
gyrus was detected with IMGENEX-5187A for avian influenza A NP and visualized with
DAB. Brown stain indicates the presence of virus .C,F: Higher magnification of box in
panel B and E, respectively. C: Arrows point to cellular debris. F: Arrow points to a
blood vessel negative for viral antigen. G-J: Representative sections of the hippocampus.
G: H&E stained section, H: viral antigen stained section of the hippocampus. H, J:
Higher magnification of box in panel G. Higher magnification of box in panel G and I,
respectively.
Figure 6. Aerosolized H5N1 results in widespread infection and pathological
observations in the thalamus.
A,B: Viral antigen in the thalamus of ferrets exposed to 0.2 PFU was detected with
IMGENEX-5187A for avian influenza A NP and visualized with DAB. Brown stain
indicates the presence of virus. B: Higher magnification of box in panel A. Asterisks
denote foci of H5N1 infection. C: H&E stained section of the thalamus demonstrating
perivascular cuffing around a blood vessel. D: Viral antigen was detected in the next
99

sequential section of panel C. Note the absence of positive staining in the vessel. E:
Representative sections of the thalamus of ferrets exposed to 31.88 PFU of H5N1, stained
with H&E. Arrows denote areas of inflammation. F: Higher magnification of box in
panel E. G: H&E stained section of the epithalamus of a ferret exposed to the low dose of
H5N1. H: Next sequential section of section in panel G, stained for viral antigen. Arrow
denotes blood vessel negative for viral antigen among a foci of positive infection.
Figure 7. Viral antigen and cell death are detected in the cerebellum of ferrets
following aerosol exposure.
Cerebellar sections stained with A-C: H&E or D-F: IMGENEX-5187A for avian
influenza A NP and visualized with DAB. Brown stain indicates the presence of virus.
A:Mild cellular debris was observed in the area of viral infection in the Purkinje cells of
the cerebellum. B: Moderate cell death was observed in the fastigial (denoted by asterisk)
and interpositus (denoted by pound sign) nuclei. C: Higher magnification of fastigial
nucleus from B. Dashed arrow points to cellular debris. D: Area of positive infection in
the Purkinje cell layer of the cerebellum. Arrow points to a Purkinje cell positive for viral
antigen. E: The fastigial (denoted by asterisk) and interpositus (denoted by pound sign)
nuclei were positive for viral antigen by immunohistochemistry. F: Higher magnification
of avian influenza nucleoprotein positive area from panel D. Arrowhead points to a cell
positive for viral antigen.
Figure 8. Aerosol exposure to H5N1 results in significant destruction in the brain
stem of ferrets.
A-D: H&E stained sections of the brain stem of ferrets exposed H5N1 A: Circle
identifies a nucleus with karyorrhexis and the arrow indicates perivascular cuffing of a
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blood vessel. Ferret was exposed to 0.2 PFU of H5N1.E: Section subsequent to the H&E
stained section in panel A with a circle indicating the same area and the arrow indicating
the absence of positive staining in the blood vessel. B: Brain stem of a ferret exposed to
the higher dose of H5N1. C: Higher magnification of the box in panel B. Arrows
indicated cellular debris. F: Section subsequent to that in panel B stained for viral
antigen. G: Higher magnification of box in panel F. D: Brain stem of a ferret exposed to
the higher dose of H5N1 showing marked inflammation. H: Section subsequent to that in
panel D stained for viral antigen.
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Table
Table 1. Prevalence of neurological signs in ferrets.

Dose
(PFU)
0
0.2
32

Number of Ferrets with
Neurological Signs/Total
Ferrets in Group
0/6
2/6
6/6

Day of
onset
NA
6, 7
5, 6, 7, 8
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Chapter Four: Discussion
Summary of Studies
These studies sought to determine the spatial and temporal kinetics of the
neuropathogenesis of highly pathogenic avian influenza (HPAI) in the ferret model
following both nasal and deep lung deposition. Specifically, we examined neuroinvasion
of HPAI into the ferret brain following infection and identified regions of the central
nervous system (CNS) that are susceptible and permissive to HPAI infection.
Furthermore, we correlated the neurological sequelae with neuroanatomical locations of
lesions.
Two viruses, one isolated from the initial H5N1 outbreak in Hong Kong in 1997
(HK483) and one from the re-emergence in 2004 (VN1203) were introduced to ferrets at
low doses to more closely represent natural infection in individuals. Investigating
differences in neuropathogenesis between two well-characterized H5N1 viruses with
differing lethality may guide future research in identifying viral determinants of
neuropathogenesis. Furthermore, increased understanding of the correlations between the
detection of virus outside of the respiratory tract with neurological signs observed during
the course of disease may aid clinicians in the quick diagnosis of H5N1 in the absence of
typical respiratory symptoms of infection. Importantly, we showed that HPAI deposition
into the deep lung also results in neuroinvasion and clinical manifestations of CNS
infection.
Intranasal instillation of low doses of VN1203 in ferrets resulted in 100% lethality
with 80% of ferrets exhibiting neurological signs. Detailed examination of the
neuropathogenesis of this virus revealed that VN1203 instillation resulted in widespread
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multifocal infection in the brain with mild inflammation and focal areas of cell death as
described by foci of nuclear debris – karyorrhexis. HK483 infection resulted in 20%
lethality and no neurological signs of infection. Samples analyzed for viral load in the
brain demonstrated VN1203 could replicate to high titers in the olfactory bulb, cerebral
cortex, cerebellum, and brain stem while HK483 could not be isolated from these
sections. Interestingly, viral RNA could be detected in the brains of HK483 infected
ferrets, but at later time points (6 and 8 days post-infection). The differences in lethality
could not be attributed to viral replication in the respiratory tract or differences in the
lung pathology. We concluded that the increased lethality observed following intranasal
instillation of a low dose of VN1203 was due to the neuropathogenesis of the virus and
the inability of HK483 to replicate in the brain resulted in a more typical respiratory
illness that the ferrets could clear and ultimately recover.
Comparable to observations following a low dose intranasal instillation of
VN1203, aerosol exposure to a low dose of the same virus resulted in neurological signs
of infection and 100% lethality although the mean time-to-death was delayed compared
to intranasally instilled ferrets. The manifestation of neurological signs of infection
suggests CNS involvement is not a consequence of intranasal delivery and virus delivered
as an aerosol to the deep lung can also disseminate to and replicate in the brain.
Furthermore, ferrets exposed via aerosol were found to have more inflammation than
observed following intranasal instillation and foci of infection were observed to be more
widespread and larger than those following intranasal instillation. Lesions in multiple
areas of the CNS following aerosol exposure support multiple routes of neuroinvasion in
the ferret.
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Lethality is higher in cases of influenza infection that involve the CNS (1, 2);
therefore it is important to understand where the virus is replicating in the brain, how it is
getting there, and what neurological signs to look for as indications H5N1 has reached
the brain. Further research in this area could identify aspects of the virus to target in order
to prevent influenza from reaching the CNS and resulting in death.

Routes of H5N1 infection in the CNS
Despite the argument that H5N1 reaches the brain as a result of intranasal
instillation, we showed widespread dissemination in the CNS of ferrets exposed to H5N1
via aerosol as well. The nose-only aerosol exposure model used in this study presented
H5N1 particles that were approximately 2.1 μm mass median aerodynamic diameter
(MMAD) which has been shown to be respirable for ferrets (3, 4). As the ferrets inspire
small particles of aerosolized virus, the virus attaches to cells in the nasal epithelium
where it can begin to replicate. Small particles are also inhaled into the lower respiratory
tract and can replicate in the lung. There are several routes that have been suggested as
possible ways virus can travel from the nose into the CNS (5, 6) and from the lung to the
CNS (7).
The olfactory tract is the first route considered to be a major conduit of
neuroinvasion (5, 7-9). The neuroepithelium of the nasal turbinates include olfactory
nerve fascicles in the olfactory mucosa that extend through the cribriform plate to the
main olfactory bulb (MOB), which we showed to have high titers of H5N1 at the time of
death. Additionally, we showed in situ staining for viral antigen in the olfactory bulb and
could describe specific areas of the olfactory bulb that were consistently infected.
Consistent with the suggestion that virus travels via the olfactory nerves, virus was
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detected in and around the glomeruli which are found in the MOB. The glomeruli contain
mitral cells and tufted cells whose dendrites synapse with the axons of olfactory receptor
nerves and whose glia pass through the olfactory nerve layer. Not surprisingly, mitral
cells were also commonly infected.
Secondary projections from the MOB to the olfactory cortex provide a plausible
route of further dissemination in the CNS. Mitral cells also project through the olfactory
tract and lateral olfactory stria to the ipsilateral olfactory cortex over the piriform lobe.
Following both intranasal instillation and aerosol exposure, viral antigen was detected in
the olfactory cortex and piriform lobe consistent with the olfactory nerve as a route of
infection. Lesions and viral antigen in the piriform lobe could affect a ferret’s olfactory
sensation leading to an inability to locate food resulting in weight loss.
Notably, the connections from the mitral cells of the MOB to the piriform lobe,
located caudally to the MOB, do not pass through the thalamic nuclei, which were also
infected with H5N1 following both methods of virus exposure. However, there appeared
to be more foci of infection in the thalamus of ferrets exposed to aerosolized H5N1. The
thalamic nuclei only receive axons from other diencephalic and telencephalic sources and
not from the olfactory tract. Possible origins of the virus that reach the thalamus could be
the cingulate gyrus and the frontal cortex; both of which contained multifocal and
widespread H5N1 infection following both routes of exposure.
The trigeminal nerve (cranial nerve (CN) V) has also been suggested as a route of
infection into the CNS (7). This nerve innervates the face and is responsible for facial
sensations and mastication. Mouse studies of H5N1 infection suggested virus could travel
via the trigeminal nerve from the face due to the close proximity to the nose where virus
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is typically presented (7). Following both intranasal instillation and aerosol exposure in
the studies discussed here, viral antigen was detected by immunohistochemistry in the
spinal tract of CN V, supporting the possibility that the virus could reach the CNS via the
trigeminal nerve in addition to the olfactory nerve. Importantly, the trigeminal nerve does
not traverse the brain via the same path as the olfactory nerve and enters the pons through
the caudolateral part of the transverse fibers of the pons.
The cell bodies of the glossopharyngeal (CN IX), vagus (CN X), and accessory
(CN XI) nerves are located in the nucleus ambiguus, which is found in the brain stem.
The vagus nerve reaches through the neck and thorax and branches to innervate the
esophageal muscles, larynx, trachea, and bronchi as well as the heart and other viscera.
Since influenza viruses are known to infect and replicate in the respiratory tract, the
complex innervations of the lung by the vagus nerve provide a route for the virus to reach
the CNS without passing through the olfactory or trigeminal nerves. The brain stem of
ferrets in these studies, regardless of the exposure method, was widely infected with
H5N1 as determined by immunohistochemistry. While the nucleus ambiguus was not
specifically examined, more detailed analysis of brain stem sections from future studies
could describe whether or not the vagus nerve was likely a route of infection by H5N1 in
these models. Finally, the nerves of the sympathetic nervous system have been suggested
as routes of H5N1 infection in the brain using a mouse model of infection (7). The
studies presented here did not examine the sympathetic nerve ganglia; however, future
studies could ascertain whether or not H5N1 can travel up the sympathetic nerve in the
ferret model of intranasal or aerosol infection.
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Correlation of neurological signs of infection with lesions in the CNS
Understanding the correlation of neurological signs observed during the course of
infection could aid clinicians in a quicker diagnosis of avian influenza infection when
patients present without the typical respiratory symptoms or with neurological signs in
addition to respiratory symptoms. Lesions in discrete and identifiable areas of the brain
with described functions could result in neurological sequelae that could be used in
differential diagnoses and treatment plans (10). Clinical signs of damage to various areas
of the CNS have been characterized for the cerebrum, diencephalon, mesencephalon,
cerebellum, vestibular system, and brain stem (10). Using these described clinical signs,
we could identify regions of the brain to examine for lesions caused by H5N1 infection
that could explain the neurological signs observed.
VN1203 infection resulted in widespread and severe cytopathology in the
neuroepithelium of the nasal turbinates. Lesions in this area are known to result in altered
perception, particularly as an olfactory deficit (10). An inability to smell food could
hinder the infected ferrets from eating and could contribute to some of the weight loss
observed during the studies. In addition to the disrupted neuroepithelium following
intranasal instillation with H5N1, exposure to aerosolized VN1203 resulted in
widespread inflammation and hemorrhaging in the olfactory bulb of infected ferrets.
Nuclear debris was consistently observed around the glomeruli and throughout the
various layers of the main olfactory bulb. These lesions and the moderate inflammation
apparent in this area could also impair the ferrets’ ability to smell and find food.
Widespread and multifocal inflammation was also observed throughout the
cerebral cortex. Additionally, we observed areas of distinct karyorrhexis in the cerebral
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cortex that were also positive for viral antigen in sequentially cut sections. The damage to
this area could explain the paresis and paralysis observed following both methods of
exposure (10).
Within the diencephalon, widespread lesions and inflammation were observed,
especially in areas positive for virus. Damage to the thalamus and hypothalamus could
also explain weight loss due to a “deranged appetite” – anorexia, and disrupted
thermoregulation, which was more evident following aerosol exposure. Additionally,
inflammation in the thalamus appeared to be more widespread with more foci of infection
and lesions after aerosol exposure than following intranasal instillation. The observed
convulsions could have been seizures although a diagnosis of seizures could not be
confirmed with the techniques used on these studies. Lesions to the thalamus could result
in seizures (10) and future studies should be designed to look for neurological signs
specific to damage in the thalamus and more thoroughly studied.
Some ferrets experienced what was described as “shaking or shivering,” which
could have been tremors or chills, during the course of infection and this sign could be
attributed to damage in the cerebellum (10). In these studies, the Purkinje cells of the
cerebellar cortex were widely infected with VN1203, regardless of the infection method,
and lesions and viral antigen were detected in the deep cerebellar nuclei. The fastigial
nuclei are connected to the vestibular nuclei and damage to this connection could
interfere with hearing. Hearing loss could explain the “loss of startle” observed in ferrets
exposed to aerosolized VN1203. The dentate nuclei of the cerebellum are partially
responsible for controlling voluntary movement and the lesions observed in this area
could have resulted in the ferrets’ inability to control movement.
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Widespread inflammation and lesions were observed in the brain stem of infected
ferrets and damage to the reticular formation of the brain stem could result in lameness,
paresis and paralysis, and weakness. Viral antigen and lesions were consistently found in
this structure of the brain stem following VN1203 infection.
Lesions to the cranial nerves could also result in many neurological signs of
infection. Damage to CN III, CN IV, CN V, CN VI, CN VII, CN X could also explain
paresis and paralysis. Lesions in CN VIII could cause head tilt, which was observed
following infection with VN1203. More detailed studies designed to examine these
specific cranial nerves should be conducted to further investigate which nerve(s) are
involved in the neurological signs recorded following VN1203 infection.
While we did not look specifically at viremia as contributing to CNS infection, it
is plausible that HPAI viruses, which bind to red blood cells, could infect extrapulmonary
organs via the hematogenous route (11, 12). However, we did examine blood vessels in
formalin-fixed paraffin embedded tissue sections that were probed for HPAI antigen and
did not find any indication of HPAI virus in the endothelial cells or cells in the lumen of
the vessels. This route should be further explored in future studies of HPAI infection in
ferrets.

Limitations of the Study
While ferrets provide an excellent model for studying the pathogenesis of
influenza viruses, cost, care, and ethical considerations typically limit the number of
animals available and allowed on a study. Also, the outbred nature of the subjects limits
the reproducibility that is available for inbred mouse models, permitting variation
between animals that cannot be controlled. While care was taken to take samples
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consistently between studies and trim formalin-fixed paraffin embedded sections
uniformly, the inherent anatomical variation between subjects did not always permit this.
Organ weights and sizes varied between animals so standard sampling techniques did not
always account for these variations (e.g., a specific weight of tissue was removed for
virus cultures; however this may not have been the same percentage of the weight of each
respective organ between animals).
More detailed tracking of the routes of neuroinvasion could be accomplished
using a fluorescently tagged HPAI virus and appropriate imaging platforms. Live
tracking studies would provide further details on the route(s) HPAI viruses utilize to
disseminate from the respiratory tract to extrapulmonary tissues. Furthermore, direct
inoculation of HPAI virus (neurovirulent and non-neurovirulent) into the brain would
distinguish whether less lethal, non-neurovirulent strains could replicate in neuronal
tissue but lack a mechanism for disseminating to the CNS or if the deficiency is in the
viral replication process in neuronal cells. We pursued intracranial inoculations but due to
ethical and logistical constraints, this route of exposure could not be examined.
While these limitations exist with utilizing the ferret model, they are carefully
considered during the study design, sampling process, and analysis. They are consistent
between studies and controlled for as much as possible.

Future Studies
The nose-only aerosol method of H5N1 exposure in ferrets is an invaluable model
for studying the effects of HPAI infection in a physiologically relevant way. Low doses
of virus should continue to be used to better represent the amount of virus a human would
be exposed to as an aerosol in a natural infection.
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The findings of these studies have provided great insight into the
neuropathogenesis of H5N1, specifically the lethal strain, VN1203. While we have
identified brain regions that are susceptible and permissive to VN1203 infection, future
studies should be designed to examine detailed routes of infection as well as be designed
to study specific basal nuclei in the brain.
Time-course studies that seek to model the route of neuropathogenesis in the
ferret following aerosol exposure to HPAI should be designed to take frequent samples
for measuring viral load in the CNS, other extra-pulmonary regions, and the respiratory
tract. Fixed samples should be trimmed with precision to allow for identical slides to be
cut from multiple animals for more exact comparisons and power in statistically
analyzing differences in localization, and confidently identifying specific brain regions.
The reverse genetics system has been established and optimized for influenza
research and many studies have used the system to discover viral determinants of
lethality (12-23). Studies that seek to identify viral determinants of neuropathogenesis in
an aerosol model of infection would be greatly beneficial in identifying new virulence
markers that could enhance surveillance of newly emerging HPAI viruses. Of particular
interest are the segments that comprise the ribonucleoprotein (i.e., PB1, PB2, and PA).
We can hypothesize that differences in these segments permit VN1203 to replicate to
high titers in the brain and result in severe lesions that cause enough damage to manifest
as neurological signs. Another segment of interest is the HA of neurovirulent strains. This
surface glycoprotein may enhance attachment and entry into neuronal cells permitting
replication and dissemination throughout the CNS. Finally, the NS segment would be
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interesting to study in order to determine if differences in the immune response contribute
to the increased lethality in the neuropathogenic strains of HPAI.

Conclusions
In the first study described in this dissertation, we sought to identify determinants
of lethality for a virulent H5N1 strain from 2004 (VN1203) and for a less virulent isolate
from 1997 (HK483) following intranasal instillation of a low dose in ferrets. We
concluded the increased lethality of VN1203 was due to the neuropathogenesis of the
virus. High viral loads in the olfactory bulb, cerebral cortex, cerebellum, and brain stem
were measured by microplaque assays and visualized by immunohistochemical staining
for viral antigen. These analyses resulted in identifying specific regions of the brain as
susceptible and permissive to infection by VN1203.
The second study highlights the neurological sequelae of VN1203 infection
following aerosol exposure of a low dose deep into the lung. We showed aerosolized
VN1203 resulted in widespread infection with more foci of infection and more severe
inflammation than observed following intranasal instillation. The widespread and
multifocal nature of the infection aided in our analysis of identifying lesions in specific
neuroanatomical regions that correlated with neurological signs of infection. Importantly,
this study showed that H5N1 infection could still result in neurological manifestations of
disease when ferrets were exposed to the more natural route of infection.
Mouse models of HPAI infection are often used to examine the
neuropathogenesis of HPAI viruses because many more H5N1 strains are neuroinvasive
to mice (7, 9, 24-28). To our knowledge these are the first studies describing brain
regions susceptible and permissive to VN1203 replication in the ferret model, particularly

121

following low dose aerosol exposure, which is a more physiologically relevant model
than intranasal instillation. Widespread CNS involvement and the consistent observation
of neurological signs of infection following aerosol exposure support the argument that
H5N1 can reach the brain via several routes of infection and it is not a consequence of
intranasal instillation. Furthermore, the manifestation of neurological signs in ferrets
following aerosol exposure recapitulate observations of CNS involvement in humans
following infection with human influenza strains as reported over the last century (1, 2936).

Importantly, increased understanding of the correlation between neurological
signs of infection, the localization of neuroanatomical lesions, and viral antigen, may
provide clinicians with more markers of avian influenza infection when presented with
cases of atypical symptoms. Finally, as more information on mechanisms of
neuropathogenesis of the virus is reported and routes of infection are better understood,
drugs aimed at blocking those specific pathways could prevent the virus from entering
the CNS and could increase survival rates following HPAI infection.
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